[
  {
    "bcr_patient_uuid": "a63ca97d-ef31-4118-9547-a6730967290f",
    "patient_ID": "TCGA.BA.4074",
    "bcr_drug_barcode": "TCGA-BA-4074-D4877",
    "bcr_drug_uuid": "63bcb5e7-c890-4f60-b14d-4a583b8f1ee9",
    "form_completion_date": "2010-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6fa62461-e721-415a-8b0f-363b84292b82",
    "patient_ID": "TCGA.BA.4075",
    "bcr_drug_barcode": "TCGA-BA-4075-D9965",
    "bcr_drug_uuid": "c96b1f60-c308-47a3-b27c-ea06cc9e54b4",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "6fa62461-e721-415a-8b0f-363b84292b82",
    "patient_ID": "TCGA.BA.4075",
    "bcr_drug_barcode": "TCGA-BA-4075-D9966",
    "bcr_drug_uuid": "76c7fe23-2fe8-4181-b3a3-24aeda9d9293",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 264,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "drug_units": "MG/M2",
    "drug_dose": 45,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "7de19081-d5fd-468c-ad0d-f6e3e8b2ad70",
    "patient_ID": "TCGA.BA.4076",
    "bcr_drug_barcode": "TCGA-BA-4076-D6283",
    "bcr_drug_uuid": "ddef241a-10c6-4dfd-bab8-4d8c367b0eac",
    "form_completion_date": "2010-12-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 2,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7de19081-d5fd-468c-ad0d-f6e3e8b2ad70",
    "patient_ID": "TCGA.BA.4076",
    "bcr_drug_barcode": "TCGA-BA-4076-D6284",
    "bcr_drug_uuid": "5da54504-1a43-4257-acb1-87e8686573ed",
    "form_completion_date": "2010-12-10",
    "pharmaceutical_therapy_drug_name": "5FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 2,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4bfbce2b-9d0b-4e8a-950f-fd8e0ba3e05a",
    "patient_ID": "TCGA.BA.4077",
    "bcr_drug_barcode": "TCGA-BA-4077-D9957",
    "bcr_drug_uuid": "528cddf3-fef8-40f7-884d-bc28302ffe6a",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 912,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1043,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "cb99fb14-641c-4fb3-bf1d-17efb8cd982a",
    "patient_ID": "TCGA.BA.5149",
    "bcr_drug_barcode": "TCGA-BA-5149-D9975",
    "bcr_drug_uuid": "be1ea051-1617-4794-9baf-b7d7817e78a4",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_dose": 100,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b3631718-9e0a-454c-bee1-8f36ebc509d8",
    "patient_ID": "TCGA.BA.5153",
    "bcr_drug_barcode": "TCGA-BA-5153-D6528",
    "bcr_drug_uuid": "b8c8e08b-9c91-472b-8030-f99dded9e6dd",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b3631718-9e0a-454c-bee1-8f36ebc509d8",
    "patient_ID": "TCGA.BA.5153",
    "bcr_drug_barcode": "TCGA-BA-5153-D6523",
    "bcr_drug_uuid": "7f8f93e1-7643-4958-aabb-867bfa5da766",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "ZOMETA",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "pharmaceutical_tx_ongoing_indicator": false,
    "pharma_type_other": "ANCILLARY AGENT",
    "regimen_number": 2,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b3631718-9e0a-454c-bee1-8f36ebc509d8",
    "patient_ID": "TCGA.BA.5153",
    "bcr_drug_barcode": "TCGA-BA-5153-D6526",
    "bcr_drug_uuid": "85a4ed84-c597-4f42-b8fe-a961cc5c868c",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2
  },
  {
    "bcr_patient_uuid": "b3631718-9e0a-454c-bee1-8f36ebc509d8",
    "patient_ID": "TCGA.BA.5153",
    "bcr_drug_barcode": "TCGA-BA-5153-D6530",
    "bcr_drug_uuid": "d2751b5a-a528-4326-b18b-dc47784924b3",
    "form_completion_date": "2010-12-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 3,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7e0575ce-670b-4035-8a90-4d35279707b2",
    "patient_ID": "TCGA.BA.5557",
    "bcr_drug_barcode": "TCGA-BA-5557-D9935",
    "bcr_drug_uuid": "a4fee25f-96a9-4e15-9d54-f2abfb2829a0",
    "form_completion_date": "2011-3-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed61706c-7fc1-4c5f-b473-7b0888ac5b73",
    "patient_ID": "TCGA.BA.6868",
    "bcr_drug_barcode": "TCGA-BA-6868-D14886",
    "bcr_drug_uuid": "3b2f71ea-6cb7-4952-8ce4-c0aa62d9a93d",
    "form_completion_date": "2011-7-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2248,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1746
  },
  {
    "bcr_patient_uuid": "ed61706c-7fc1-4c5f-b473-7b0888ac5b73",
    "patient_ID": "TCGA.BA.6868",
    "bcr_drug_barcode": "TCGA-BA-6868-D14882",
    "bcr_drug_uuid": "c9cddced-57e8-485e-a375-e67a534d9aca",
    "form_completion_date": "2011-7-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1831,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1419
  },
  {
    "bcr_patient_uuid": "ed61706c-7fc1-4c5f-b473-7b0888ac5b73",
    "patient_ID": "TCGA.BA.6868",
    "bcr_drug_barcode": "TCGA-BA-6868-D14891",
    "bcr_drug_uuid": "b32a9625-f43f-4758-ad4a-89f5d662266b",
    "form_completion_date": "2011-7-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 515
  },
  {
    "bcr_patient_uuid": "ed61706c-7fc1-4c5f-b473-7b0888ac5b73",
    "patient_ID": "TCGA.BA.6868",
    "bcr_drug_barcode": "TCGA-BA-6868-D14884",
    "bcr_drug_uuid": "03df431f-dc92-4000-b991-46698522682e",
    "form_completion_date": "2011-7-19",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY|TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 13,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 692,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 519
  },
  {
    "bcr_patient_uuid": "730c3b27-24d5-4a80-b659-db54cd2bc4fa",
    "patient_ID": "TCGA.BA.6870",
    "bcr_drug_barcode": "TCGA-BA-6870-D14204",
    "bcr_drug_uuid": "0e04b472-452f-40cf-8abf-fcefd3b40235",
    "form_completion_date": "2011-7-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3e5f451a-5882-4914-ae1a-95c898c2bcca",
    "patient_ID": "TCGA.BA.6872",
    "bcr_drug_barcode": "TCGA-BA-6872-D14865",
    "bcr_drug_uuid": "e9353bdd-fe93-4bad-9786-fd4d424d9db0",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bf6b931e-cb2e-4cc0-b603-e9fc71fdc509",
    "patient_ID": "TCGA.BA.6873",
    "bcr_drug_barcode": "TCGA-BA-6873-D14873",
    "bcr_drug_uuid": "935866ce-b2bc-47fd-8d79-529515f4704f",
    "form_completion_date": "2011-7-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "28D2FD8E-ABE9-4EA3-87E4-4F2B61A33C90",
    "patient_ID": "TCGA.BA.A4IF",
    "bcr_drug_barcode": "TCGA-BA-A4IF-D51699",
    "bcr_drug_uuid": "72A21393-F5D6-495E-84DB-000D013180AC",
    "form_completion_date": "2013-11-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "54B295D4-6315-4416-BDE7-A221859F965C",
    "patient_ID": "TCGA.BA.A4IG",
    "bcr_drug_barcode": "TCGA-BA-A4IG-D55785",
    "bcr_drug_uuid": "737DB7A8-CBB2-4758-ADD3-3A873069F0E3",
    "form_completion_date": "2014-1-15",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BD75D8EE-916B-4ABC-BF33-BCE6A4217076",
    "patient_ID": "TCGA.BA.A4IH",
    "bcr_drug_barcode": "TCGA-BA-A4IH-D55787",
    "bcr_drug_uuid": "100E1715-44FF-4BB6-9704-C2925F3056AD",
    "form_completion_date": "2014-1-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B39C64BB-122D-44B3-9672-D0DC8468CA93",
    "patient_ID": "TCGA.BA.A6D8",
    "bcr_drug_barcode": "TCGA-BA-A6D8-D45515",
    "bcr_drug_uuid": "E48C2867-CB04-45D0-9247-25DDEA0676A6",
    "form_completion_date": "2013-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "17885905-280F-40FA-943E-346ED45403EA",
    "patient_ID": "TCGA.BA.A6DA",
    "bcr_drug_barcode": "TCGA-BA-A6DA-D45523",
    "bcr_drug_uuid": "13D2DADB-5EF5-4C42-9962-C48136399B87",
    "form_completion_date": "2013-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C4060CA5-33E0-4C83-B91C-742D75059BDC",
    "patient_ID": "TCGA.BA.A6DD",
    "bcr_drug_barcode": "TCGA-BA-A6DD-D45576",
    "bcr_drug_uuid": "F7273590-003F-4BFA-B78A-0035C0B93757",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CB78EFB3-BC29-4DE7-9128-FDC4F9539B48",
    "patient_ID": "TCGA.BA.A6DI",
    "bcr_drug_barcode": "TCGA-BA-A6DI-D45611",
    "bcr_drug_uuid": "68373786-E3EC-411F-BF99-B2F086C61929",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DE19185-3517-4E30-925B-7EB1F5079EC2",
    "patient_ID": "TCGA.BA.A6DJ",
    "bcr_drug_barcode": "TCGA-BA-A6DJ-D45625",
    "bcr_drug_uuid": "508B061D-2F5E-4CF9-BFE5-6FA9F6CCB2F6",
    "form_completion_date": "2013-7-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C9A36EB5-AC3E-424E-BC2E-303DE7105957",
    "patient_ID": "TCGA.BA.A6DL",
    "bcr_drug_barcode": "TCGA-BA-A6DL-D58934",
    "bcr_drug_uuid": "3CA53D1F-7B87-46DB-A1C5-5143BB2EBA01",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C9A36EB5-AC3E-424E-BC2E-303DE7105957",
    "patient_ID": "TCGA.BA.A6DL",
    "bcr_drug_barcode": "TCGA-BA-A6DL-D58935",
    "bcr_drug_uuid": "39281D5B-B576-4367-A6A0-0C35CD494FC4",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C9A36EB5-AC3E-424E-BC2E-303DE7105957",
    "patient_ID": "TCGA.BA.A6DL",
    "bcr_drug_barcode": "TCGA-BA-A6DL-D58936",
    "bcr_drug_uuid": "34CCA937-9C4B-481A-BAC8-04A2B89D1435",
    "form_completion_date": "2014-4-29",
    "pharmaceutical_therapy_drug_name": "LAPATINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A2D42990-747C-4618-88DD-E2DECE8E566F",
    "patient_ID": "TCGA.BA.A8YP",
    "bcr_drug_barcode": "TCGA-BA-A8YP-D57522",
    "bcr_drug_uuid": "5B1DEBA1-9AA7-42B1-91D2-05322DC09136",
    "form_completion_date": "2014-3-13",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05f01280-bf77-4682-a7a8-20dd0eac77bd",
    "patient_ID": "TCGA.BB.4223",
    "bcr_drug_barcode": "TCGA-BB-4223-D20412",
    "bcr_drug_uuid": "c91a184c-ad1a-4707-baab-92a464725a0c",
    "form_completion_date": "2012-1-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "58574e35-8a30-4207-b127-59fff7c87a43",
    "patient_ID": "TCGA.BB.4224",
    "bcr_drug_barcode": "TCGA-BB-4224-D19841",
    "bcr_drug_uuid": "894265a0-4a7c-4bf6-b6f4-5cd369efaf4b",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "58574e35-8a30-4207-b127-59fff7c87a43",
    "patient_ID": "TCGA.BB.4224",
    "bcr_drug_barcode": "TCGA-BB-4224-D19842",
    "bcr_drug_uuid": "6c19f784-9f5f-4b82-8b86-139683be4b79",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "58574e35-8a30-4207-b127-59fff7c87a43",
    "patient_ID": "TCGA.BB.4224",
    "bcr_drug_barcode": "TCGA-BB-4224-D19843",
    "bcr_drug_uuid": "0cb914b5-6dc8-4911-97a6-42457d3cf741",
    "form_completion_date": "2011-12-22",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2786,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2799,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "58574e35-8a30-4207-b127-59fff7c87a43",
    "patient_ID": "TCGA.BB.4224",
    "bcr_drug_barcode": "TCGA-BB-4224-D19774",
    "bcr_drug_uuid": "c20f37a0-8d1c-4a3f-ae8c-c3a3574b4eca",
    "form_completion_date": "2011-12-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "c1f50a22-38df-41cc-a1f4-f7985504a7ac",
    "patient_ID": "TCGA.BB.4225",
    "bcr_drug_barcode": "TCGA-BB-4225-D20431",
    "bcr_drug_uuid": "0407d87c-3797-4d73-b6eb-b9b522297bba",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1
  },
  {
    "bcr_patient_uuid": "b8ac8500-abcd-40c4-9c24-7af557fd260a",
    "patient_ID": "TCGA.BB.4227",
    "bcr_drug_barcode": "TCGA-BB-4227-D20433",
    "bcr_drug_uuid": "6427464f-edd6-45a2-97b8-8c0b4d46b173",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b8ac8500-abcd-40c4-9c24-7af557fd260a",
    "patient_ID": "TCGA.BB.4227",
    "bcr_drug_barcode": "TCGA-BB-4227-D20432",
    "bcr_drug_uuid": "2b97a0b5-83ad-4595-8bd6-f189c149e085",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "1ae087ac-63f0-4cf9-b698-f5c13e1f4681",
    "patient_ID": "TCGA.BB.7861",
    "bcr_drug_barcode": "TCGA-BB-7861-D65452",
    "bcr_drug_uuid": "CEE45CF8-4DDF-485C-AEDC-63DADD067CFA",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f87f7cee-e9bd-45cc-a740-3d8ffa9746d3",
    "patient_ID": "TCGA.BB.7864",
    "bcr_drug_barcode": "TCGA-BB-7864-D65448",
    "bcr_drug_uuid": "6B71BB1A-DA2D-4125-94C8-52E7AB2D1407",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16d52afb-a954-4cb3-b168-c1501208f691",
    "patient_ID": "TCGA.BB.7866",
    "bcr_drug_barcode": "TCGA-BB-7866-D65427",
    "bcr_drug_uuid": "1D7CB457-F6EF-47BB-BF72-32DCF869F276",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "80593c77-4530-413b-bb05-adca5d43bb82",
    "patient_ID": "TCGA.BB.7872",
    "bcr_drug_barcode": "TCGA-BB-7872-D65437",
    "bcr_drug_uuid": "297C2D7D-9543-4B23-B6E7-374CB2C7CC64",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F35A0655-7504-4BD6-A9F3-6F3E59FD84B1",
    "patient_ID": "TCGA.BB.A5HU",
    "bcr_drug_barcode": "TCGA-BB-A5HU-D42910",
    "bcr_drug_uuid": "6C67DA57-560F-46C6-A3F3-6E663790DC1E",
    "form_completion_date": "2013-6-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0394060D-010E-405F-983D-DB525F01F2C3",
    "patient_ID": "TCGA.BB.A5HY",
    "bcr_drug_barcode": "TCGA-BB-A5HY-D43907",
    "bcr_drug_uuid": "E51C395A-C307-44A2-A0A7-C9284F235383",
    "form_completion_date": "2013-6-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03C3AE62-D0AA-412E-BD3C-4577FC9F919C",
    "patient_ID": "TCGA.BB.A6UM",
    "bcr_drug_barcode": "TCGA-BB-A6UM-D65420",
    "bcr_drug_uuid": "EEC81C40-40F4-4307-89D2-1F65D23FA652",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5da2dbde-735b-4f05-b6d7-76de54d6d6ac",
    "patient_ID": "TCGA.CN.4726",
    "bcr_drug_barcode": "TCGA-CN-4726-D10835",
    "bcr_drug_uuid": "be221675-cfcd-4752-839a-cb367153d4e4",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/M2/WK",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "12d05e8f-8d13-47c1-b713-2250f6abcef9",
    "patient_ID": "TCGA.CN.4727",
    "bcr_drug_barcode": "TCGA-CN-4727-D10840",
    "bcr_drug_uuid": "387ea7b9-504d-4bfc-adb0-f9273bd4bc4b",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/M2/WK",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7152edc3-0a5b-4aed-b0c6-63f913dff272",
    "patient_ID": "TCGA.CN.4728",
    "bcr_drug_barcode": "TCGA-CN-4728-D10848",
    "bcr_drug_uuid": "dc6b6705-34ec-4c39-8f9b-79bee2da6c7f",
    "form_completion_date": "2010-4-28",
    "pharmaceutical_therapy_drug_name": "VECTIBIX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7152edc3-0a5b-4aed-b0c6-63f913dff272",
    "patient_ID": "TCGA.CN.4728",
    "bcr_drug_barcode": "TCGA-CN-4728-D10846",
    "bcr_drug_uuid": "7160c518-a7f4-4b43-a8a6-147a30bed55b",
    "form_completion_date": "2011-4-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 7,
    "drug_units": "MG/M2/WK",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "50e25a4b-2eb2-4770-9a2d-8922a1e0ab56",
    "patient_ID": "TCGA.CN.4731",
    "bcr_drug_barcode": "TCGA-CN-4731-D10894",
    "bcr_drug_uuid": "5b1e2172-4a88-4d66-a2b1-1bbfc3b32648",
    "form_completion_date": "2011-4-29",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 301,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/M2/WK",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "50e25a4b-2eb2-4770-9a2d-8922a1e0ab56",
    "patient_ID": "TCGA.CN.4731",
    "bcr_drug_barcode": "TCGA-CN-4731-D20686",
    "bcr_drug_uuid": "a0702d5c-599f-444a-9a1b-3d1a911376a1",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "50e25a4b-2eb2-4770-9a2d-8922a1e0ab56",
    "patient_ID": "TCGA.CN.4731",
    "bcr_drug_barcode": "TCGA-CN-4731-D36092",
    "bcr_drug_uuid": "CC4F8925-0183-4D8D-A86A-EE7453FD1848",
    "form_completion_date": "2012-10-18",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 827,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 869,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "50e25a4b-2eb2-4770-9a2d-8922a1e0ab56",
    "patient_ID": "TCGA.CN.4731",
    "bcr_drug_barcode": "TCGA-CN-4731-D36094",
    "bcr_drug_uuid": "8F881032-DBC0-4BC4-8C23-E3BA38095655",
    "form_completion_date": "2012-10-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 937,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 958,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "fe844945-3ea9-449e-993c-df392fabcfd0",
    "patient_ID": "TCGA.CN.4735",
    "bcr_drug_barcode": "TCGA-CN-4735-D10899",
    "bcr_drug_uuid": "4e50614f-8814-4ed7-b58f-ed86d85017e3",
    "form_completion_date": "2011-4-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_cycles": 3,
    "drug_units": "MG/M2/WK",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fe844945-3ea9-449e-993c-df392fabcfd0",
    "patient_ID": "TCGA.CN.4735",
    "bcr_drug_barcode": "TCGA-CN-4735-D10900",
    "bcr_drug_uuid": "c61e070f-7f94-453f-8706-df70e5a03fb0",
    "form_completion_date": "2011-4-29",
    "pharmaceutical_therapy_drug_name": "VECTIBIX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_units": "MG/KG",
    "drug_dose": 2.5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0fb3e5ff-54f0-43c5-9322-541bb7825e7f",
    "patient_ID": "TCGA.CN.4736",
    "bcr_drug_barcode": "TCGA-CN-4736-D10927",
    "bcr_drug_uuid": "30badbe5-2cb4-485e-bd1d-ebc6e8552ba3",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 322,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1f744ada-6de1-446d-b62c-76a7fc8b40af",
    "patient_ID": "TCGA.CN.4737",
    "bcr_drug_barcode": "TCGA-CN-4737-D10937",
    "bcr_drug_uuid": "f0952334-2f5c-4d6f-9f2f-68072c695a88",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "VECTIBIX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "1f744ada-6de1-446d-b62c-76a7fc8b40af",
    "patient_ID": "TCGA.CN.4737",
    "bcr_drug_barcode": "TCGA-CN-4737-D10934",
    "bcr_drug_uuid": "f4c7ec15-db76-4158-b3b0-605213e15e9b",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "7e3b90c1-8772-4e12-8050-a156558beb82",
    "patient_ID": "TCGA.CN.4739",
    "bcr_drug_barcode": "TCGA-CN-4739-D9476",
    "bcr_drug_uuid": "bc61a36c-e119-4661-8146-2e1edb26f96f",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e37c83dc-c2c4-4e5f-a57b-39ffcf9aa3cf",
    "patient_ID": "TCGA.CN.4740",
    "bcr_drug_barcode": "TCGA-CN-4740-D10988",
    "bcr_drug_uuid": "a40260f1-e16e-4370-9bd3-9e38d8d1e58d",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "e37c83dc-c2c4-4e5f-a57b-39ffcf9aa3cf",
    "patient_ID": "TCGA.CN.4740",
    "bcr_drug_barcode": "TCGA-CN-4740-D10989",
    "bcr_drug_uuid": "d12954a0-0c1c-48eb-8e1b-5a23b22698c4",
    "form_completion_date": "2011-5-2",
    "pharmaceutical_therapy_drug_name": "EVEROLIMUS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 757,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 791,
    "drug_cycles": 1,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "277b02e9-ded5-4980-845d-af53690000ac",
    "patient_ID": "TCGA.CN.4741",
    "bcr_drug_barcode": "TCGA-CN-4741-D11043",
    "bcr_drug_uuid": "0f3d429f-a513-443b-b1e0-ce4c4fbd1aa3",
    "form_completion_date": "2011-5-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "277b02e9-ded5-4980-845d-af53690000ac",
    "patient_ID": "TCGA.CN.4741",
    "bcr_drug_barcode": "TCGA-CN-4741-D69608",
    "bcr_drug_uuid": "95F7AC03-5CD2-42ED-917F-6FFFD246600F",
    "form_completion_date": "2015-1-15",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1771,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1778,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "444e5bfc-d4e5-4b0d-b96d-88ecea8873e9",
    "patient_ID": "TCGA.CN.4742",
    "bcr_drug_barcode": "TCGA-CN-4742-D9490",
    "bcr_drug_uuid": "138ac124-e3e2-4117-a2b1-9e72f9543b6e",
    "form_completion_date": "2011-3-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4e0c62d-f2f6-4243-9e0f-ae2ad4ca4bb8",
    "patient_ID": "TCGA.CN.5358",
    "bcr_drug_barcode": "TCGA-CN-5358-D10100",
    "bcr_drug_uuid": "37dbe7fb-7d7a-4925-82c8-08f3f6de109a",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b4e0c62d-f2f6-4243-9e0f-ae2ad4ca4bb8",
    "patient_ID": "TCGA.CN.5358",
    "bcr_drug_barcode": "TCGA-CN-5358-D10101",
    "bcr_drug_uuid": "bbd10715-5fbc-41cb-84ad-a254e9355ec3",
    "form_completion_date": "2011-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "bfaa4b3f-3e38-478e-99b3-013f2cda80f5",
    "patient_ID": "TCGA.CN.5359",
    "bcr_drug_barcode": "TCGA-CN-5359-D11139",
    "bcr_drug_uuid": "1456374e-e04e-4a13-b6dd-7845cd4b9181",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "PANITUMUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "bfaa4b3f-3e38-478e-99b3-013f2cda80f5",
    "patient_ID": "TCGA.CN.5359",
    "bcr_drug_barcode": "TCGA-CN-5359-D11136",
    "bcr_drug_uuid": "b47651e7-2e95-4647-9b80-8e3f8c145046",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "5793879b-f663-4a10-9bd9-1acd2e189650",
    "patient_ID": "TCGA.CN.5360",
    "bcr_drug_barcode": "TCGA-CN-5360-D11047",
    "bcr_drug_uuid": "901ff2ac-5284-4b23-b1fb-35fee574c05f",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13f63218-0949-41e6-a661-c844414c45b5",
    "patient_ID": "TCGA.CN.5364",
    "bcr_drug_barcode": "TCGA-CN-5364-D11177",
    "bcr_drug_uuid": "05b57b8e-479e-4fbe-be51-1d514ce6a088",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13f63218-0949-41e6-a661-c844414c45b5",
    "patient_ID": "TCGA.CN.5364",
    "bcr_drug_barcode": "TCGA-CN-5364-D11176",
    "bcr_drug_uuid": "06b941e6-c869-4cb3-8019-ca4f5ec64875",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "30eb06a5-8e88-4c46-bebb-fb93ca07f108",
    "patient_ID": "TCGA.CN.5366",
    "bcr_drug_barcode": "TCGA-CN-5366-D11098",
    "bcr_drug_uuid": "29317f3b-46f7-48b3-9b88-ad1be4bbcb5f",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "61d0709c-d148-413b-a7b5-c0c82ed2f32f",
    "patient_ID": "TCGA.CN.5367",
    "bcr_drug_barcode": "TCGA-CN-5367-D11126",
    "bcr_drug_uuid": "2fc23b54-6d79-4aa8-b736-3fcf97c884ca",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "54dab158-eb39-4334-8b5a-bf290e6b8bb1",
    "patient_ID": "TCGA.CN.5370",
    "bcr_drug_barcode": "TCGA-CN-5370-D20384",
    "bcr_drug_uuid": "b6f5aa20-1b2c-4c5c-86fe-a94da873ec8c",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "54dab158-eb39-4334-8b5a-bf290e6b8bb1",
    "patient_ID": "TCGA.CN.5370",
    "bcr_drug_barcode": "TCGA-CN-5370-D20385",
    "bcr_drug_uuid": "46c0a0fa-6a2f-4e82-ba51-afcd0b310a13",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "54dab158-eb39-4334-8b5a-bf290e6b8bb1",
    "patient_ID": "TCGA.CN.5370",
    "bcr_drug_barcode": "TCGA-CN-5370-D20386",
    "bcr_drug_uuid": "118f2653-b67f-4da4-a82e-adc34a93f976",
    "form_completion_date": "2012-1-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d7641ca1-a062-4dd2-9414-447af7311a84",
    "patient_ID": "TCGA.CN.5374",
    "bcr_drug_barcode": "TCGA-CN-5374-D11053",
    "bcr_drug_uuid": "fdd2aa57-1849-4154-baa7-6fd8077d2354",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVESICAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "af31bf2c-8523-4376-bfa8-e2845848d651",
    "patient_ID": "TCGA.CN.6010",
    "bcr_drug_barcode": "TCGA-CN-6010-D12909",
    "bcr_drug_uuid": "0380fd4a-b2f7-4719-8902-3ee482837607",
    "form_completion_date": "2011-6-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 2,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "e7d49212-e9cb-4cd7-923a-bdfc82a4a150",
    "patient_ID": "TCGA.CN.6011",
    "bcr_drug_barcode": "TCGA-CN-6011-D12915",
    "bcr_drug_uuid": "cff99d0d-77d9-4d0e-87f8-6b1bfad911f4",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9023c9bf-02a0-4396-8161-304089957b62",
    "patient_ID": "TCGA.CN.6012",
    "bcr_drug_barcode": "TCGA-CN-6012-D12918",
    "bcr_drug_uuid": "2aee6c64-62c9-42d9-9395-9d272e94866e",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "714496c5-d221-4397-9c5a-cd2d22603e6f",
    "patient_ID": "TCGA.CN.6013",
    "bcr_drug_barcode": "TCGA-CN-6013-D12921",
    "bcr_drug_uuid": "c1510e5b-75e6-4df8-885b-58839450817b",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "ffcf851d-7fa1-4b45-911a-a3fbd74c253a",
    "patient_ID": "TCGA.CN.6016",
    "bcr_drug_barcode": "TCGA-CN-6016-D12925",
    "bcr_drug_uuid": "5f3c849a-2223-4b0e-a956-302e6eb6281e",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "23c4e2eb-142b-4fcc-a974-9a248aec3f37",
    "patient_ID": "TCGA.CN.6017",
    "bcr_drug_barcode": "TCGA-CN-6017-D12931",
    "bcr_drug_uuid": "c940082c-1adc-4531-96a4-77ed6d02dd7c",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "23c4e2eb-142b-4fcc-a974-9a248aec3f37",
    "patient_ID": "TCGA.CN.6017",
    "bcr_drug_barcode": "TCGA-CN-6017-D12930",
    "bcr_drug_uuid": "7c63d1bb-992a-477d-94eb-c24c54de186e",
    "form_completion_date": "2011-6-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "ee3061ec-273c-4bef-a325-35e9c469bf01",
    "patient_ID": "TCGA.CN.6019",
    "bcr_drug_barcode": "TCGA-CN-6019-D12971",
    "bcr_drug_uuid": "53514e53-df2d-4df6-9e6c-27c267f00251",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "ee3061ec-273c-4bef-a325-35e9c469bf01",
    "patient_ID": "TCGA.CN.6019",
    "bcr_drug_barcode": "TCGA-CN-6019-D12972",
    "bcr_drug_uuid": "8efcdd24-e738-485b-943b-583e784c212d",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "VECTIBIX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "69efde94-a9f9-49ff-9c82-028c35940eda",
    "patient_ID": "TCGA.CN.6023",
    "bcr_drug_barcode": "TCGA-CN-6023-D12963",
    "bcr_drug_uuid": "1340343d-7b35-4956-869b-977df089d4d7",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f33aa93f-b32d-4c4f-9a71-1e5ab69c6899",
    "patient_ID": "TCGA.CN.6989",
    "bcr_drug_barcode": "TCGA-CN-6989-D15308",
    "bcr_drug_uuid": "57bb7a6a-4eeb-4d4e-8a88-730d769c7b00",
    "form_completion_date": "2011-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "drug_cycles": 4,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f33aa93f-b32d-4c4f-9a71-1e5ab69c6899",
    "patient_ID": "TCGA.CN.6989",
    "bcr_drug_barcode": "TCGA-CN-6989-D69735",
    "bcr_drug_uuid": "7BCBBA95-799A-442F-BFFA-CD83EEE406DF",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 791,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f33aa93f-b32d-4c4f-9a71-1e5ab69c6899",
    "patient_ID": "TCGA.CN.6989",
    "bcr_drug_barcode": "TCGA-CN-6989-D69737",
    "bcr_drug_uuid": "79273609-8760-4E9F-9DA7-9B24C8E37E3C",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 889,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 917,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "547de7d8-c2f1-41d7-a0b4-cc6f39712301",
    "patient_ID": "TCGA.CN.6992",
    "bcr_drug_barcode": "TCGA-CN-6992-D15405",
    "bcr_drug_uuid": "e401c4ae-9e4a-4b3d-bcd9-f2a87a01dca0",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "49b94421-fe82-4f24-8ef2-820674142418",
    "patient_ID": "TCGA.CN.6996",
    "bcr_drug_barcode": "TCGA-CN-6996-D15416",
    "bcr_drug_uuid": "2cdc1e4c-68c4-4cd6-a393-4cd8ef3a5286",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "49b94421-fe82-4f24-8ef2-820674142418",
    "patient_ID": "TCGA.CN.6996",
    "bcr_drug_barcode": "TCGA-CN-6996-D33162",
    "bcr_drug_uuid": "0BE502FB-1A48-4A91-B05E-929D2A583681",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 378,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "49b94421-fe82-4f24-8ef2-820674142418",
    "patient_ID": "TCGA.CN.6996",
    "bcr_drug_barcode": "TCGA-CN-6996-D33163",
    "bcr_drug_uuid": "0027A614-EB04-4DFF-A532-A08EB2C575ED",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "VORINOSTAT",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 378,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "49b94421-fe82-4f24-8ef2-820674142418",
    "patient_ID": "TCGA.CN.6996",
    "bcr_drug_barcode": "TCGA-CN-6996-D33164",
    "bcr_drug_uuid": "24E63BC8-0948-4145-B53A-713C42A33A16",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "HSC VACCINE INJECTION",
    "pharmaceutical_therapy_type": "VACCINE",
    "days_to_drug_start": 418,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "171890ae-0391-4d8c-9bd2-090d866a2c5b",
    "patient_ID": "TCGA.CN.6997",
    "bcr_drug_barcode": "TCGA-CN-6997-D15470",
    "bcr_drug_uuid": "215bd2b3-caa7-4dcb-b46d-f8a11e93a661",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 3,
    "drug_units": "MG/ML",
    "drug_tota_dose_units": "MG/ML",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "171890ae-0391-4d8c-9bd2-090d866a2c5b",
    "patient_ID": "TCGA.CN.6997",
    "bcr_drug_barcode": "TCGA-CN-6997-D33166",
    "bcr_drug_uuid": "256F059A-84A0-495D-8E52-606718D2CBBA",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "039788ec-1364-40c7-9e9d-13dc305674e9",
    "patient_ID": "TCGA.CN.6998",
    "bcr_drug_barcode": "TCGA-CN-6998-D33173",
    "bcr_drug_uuid": "4B4A9843-9FB8-48D0-BE16-CD314DE5D251",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34AAD752-D78F-440B-ABD2-F9F939C82664",
    "patient_ID": "TCGA.CN.A498",
    "bcr_drug_barcode": "TCGA-CN-A498-D37342",
    "bcr_drug_uuid": "8B958690-5FC9-4AFE-9ECE-9F05B8741A8C",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34AAD752-D78F-440B-ABD2-F9F939C82664",
    "patient_ID": "TCGA.CN.A498",
    "bcr_drug_barcode": "TCGA-CN-A498-D61912",
    "bcr_drug_uuid": "79F7F568-96AC-4286-BCC9-CE5ECB8708D7",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 480,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 487,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34AAD752-D78F-440B-ABD2-F9F939C82664",
    "patient_ID": "TCGA.CN.A498",
    "bcr_drug_barcode": "TCGA-CN-A498-D61915",
    "bcr_drug_uuid": "D130A939-969A-487E-8B57-7CF8BCE46175",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 674,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 723,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34AAD752-D78F-440B-ABD2-F9F939C82664",
    "patient_ID": "TCGA.CN.A498",
    "bcr_drug_barcode": "TCGA-CN-A498-D61916",
    "bcr_drug_uuid": "60A67D06-0F31-41C7-A60E-3D2B35313513",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 744,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 751,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34AAD752-D78F-440B-ABD2-F9F939C82664",
    "patient_ID": "TCGA.CN.A498",
    "bcr_drug_barcode": "TCGA-CN-A498-D61917",
    "bcr_drug_uuid": "C5E1363B-CDBF-4358-B624-9AD128BCE5E3",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 744,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 751,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5FE17DDE-EF75-49A2-90F8-0647077B6CA5",
    "patient_ID": "TCGA.CN.A49A",
    "bcr_drug_barcode": "TCGA-CN-A49A-D37354",
    "bcr_drug_uuid": "C4008AB6-6D23-45C5-983B-3FEC893E9710",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B39D2880-6964-4C5B-B5A9-AB64E5CB31E8",
    "patient_ID": "TCGA.CN.A49C",
    "bcr_drug_barcode": "TCGA-CN-A49C-D37365",
    "bcr_drug_uuid": "A2AD03BA-6A36-4964-A14E-6D6A3739CE96",
    "form_completion_date": "2012-12-3",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A3F98E70-7050-46CF-A679-CA7A83F4442F",
    "patient_ID": "TCGA.CN.A63T",
    "bcr_drug_barcode": "TCGA-CN-A63T-D44206",
    "bcr_drug_uuid": "5D84D47F-741E-44AF-928F-BD8F153359E1",
    "form_completion_date": "2013-6-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D5DEFB3-8572-467D-B383-7358F802B398",
    "patient_ID": "TCGA.CN.A63W",
    "bcr_drug_barcode": "TCGA-CN-A63W-D44212",
    "bcr_drug_uuid": "62901677-998E-4F33-A650-916BE200F0C7",
    "form_completion_date": "2013-6-17",
    "pharmaceutical_therapy_drug_name": "VECTIBIX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5D5DEFB3-8572-467D-B383-7358F802B398",
    "patient_ID": "TCGA.CN.A63W",
    "bcr_drug_barcode": "TCGA-CN-A63W-D44213",
    "bcr_drug_uuid": "57F1F312-FBF1-4BEF-AEE0-FE5862A7388B",
    "form_completion_date": "2013-6-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5D5DEFB3-8572-467D-B383-7358F802B398",
    "patient_ID": "TCGA.CN.A63W",
    "bcr_drug_barcode": "TCGA-CN-A63W-D44214",
    "bcr_drug_uuid": "EB206B69-FC69-41FF-9047-C3C45209F28D",
    "form_completion_date": "2013-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "600D5316-B795-4AB2-86FC-52835059386F",
    "patient_ID": "TCGA.CN.A641",
    "bcr_drug_barcode": "TCGA-CN-A641-D44226",
    "bcr_drug_uuid": "FF077EB0-9EF5-4000-8170-C36DBCE43733",
    "form_completion_date": "2013-6-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "602F2512-00B6-44B6-9ED6-F8B010224F8C",
    "patient_ID": "TCGA.CN.A6UY",
    "bcr_drug_barcode": "TCGA-CN-A6UY-D52026",
    "bcr_drug_uuid": "BB2A54D2-09B6-4368-9778-D94FE222F2D2",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03B57FEE-55C7-4873-B7EF-E29ABD98863A",
    "patient_ID": "TCGA.CN.A6V1",
    "bcr_drug_barcode": "TCGA-CN-A6V1-D52253",
    "bcr_drug_uuid": "DDE9CCD8-1220-4675-8DBF-3FE6208E46D4",
    "form_completion_date": "2013-12-2",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "896E37FA-3A6A-481B-B790-5EE62BBDC9FA",
    "patient_ID": "TCGA.CN.A6V3",
    "bcr_drug_barcode": "TCGA-CN-A6V3-D52271",
    "bcr_drug_uuid": "19331F82-7748-4F8C-B0A3-9324E970BD23",
    "form_completion_date": "2013-12-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5AC57AEE-4BE1-4A29-A53F-343F5A3D2E86",
    "patient_ID": "TCGA.CN.A6V6",
    "bcr_drug_barcode": "TCGA-CN-A6V6-D52321",
    "bcr_drug_uuid": "1001ED02-4CE0-4DE5-AF67-E3029ACB9F10",
    "form_completion_date": "2013-12-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67560840-70FB-45FD-8572-648F74811AEC",
    "patient_ID": "TCGA.CN.A6V7",
    "bcr_drug_barcode": "TCGA-CN-A6V7-D52379",
    "bcr_drug_uuid": "F812718C-07AE-4CDB-A5EF-25A900F6F65C",
    "form_completion_date": "2013-12-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5a03e2b6-4c8b-479a-9036-9859af031da4",
    "patient_ID": "TCGA.CQ.5327",
    "bcr_drug_barcode": "TCGA-CQ-5327-D10928",
    "bcr_drug_uuid": "087fb3b8-4696-47fe-9e79-b7f83d404fb4",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "9ffa79fa-d2d8-48e1-8fd6-4b020ecf357c",
    "patient_ID": "TCGA.CQ.5330",
    "bcr_drug_barcode": "TCGA-CQ-5330-D10936",
    "bcr_drug_uuid": "7f2cfbaa-b1a9-48c4-adad-9b46c7f9674b",
    "form_completion_date": "2011-4-12",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "64260b33-dac0-4442-82c8-04f0c9ea8a01",
    "patient_ID": "TCGA.CQ.6218",
    "bcr_drug_barcode": "TCGA-CQ-6218-D18538",
    "bcr_drug_uuid": "8ef7fb03-8ad2-411e-bbea-acd539e4e1a4",
    "form_completion_date": "2011-9-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "e1670628-632d-4305-be07-9b9b6bea3350",
    "patient_ID": "TCGA.CQ.6222",
    "bcr_drug_barcode": "TCGA-CQ-6222-D18547",
    "bcr_drug_uuid": "dbe1e33d-cf3f-49bb-9219-156952973a6e",
    "form_completion_date": "2011-9-30",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_units": "MG",
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d86fd392-fa5c-4142-a647-440e6c32d478",
    "patient_ID": "TCGA.CQ.6224",
    "bcr_drug_barcode": "TCGA-CQ-6224-D19308",
    "bcr_drug_uuid": "c7de3b5d-5181-48e1-bae6-c600022ea594",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 170,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "20ece2ca-8601-4cca-aec5-0a5c0b92594d",
    "patient_ID": "TCGA.CQ.7065",
    "bcr_drug_barcode": "TCGA-CQ-7065-D21031",
    "bcr_drug_uuid": "16cbc814-e531-4d7d-9f43-bbb4ba4123c0",
    "form_completion_date": "2012-1-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 291,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 197,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 477
  },
  {
    "bcr_patient_uuid": "AE90972D-5BC2-4B53-B5FF-1B8C31F39342",
    "patient_ID": "TCGA.CQ.A4CH",
    "bcr_drug_barcode": "TCGA-CQ-A4CH-D39504",
    "bcr_drug_uuid": "BFA3063F-BAC1-47D7-B5B8-D95B3CB44D14",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e37f479f-ca05-45e4-ac6d-a974bed6e7f8",
    "patient_ID": "TCGA.CR.5243",
    "bcr_drug_barcode": "TCGA-CR-5243-D13862",
    "bcr_drug_uuid": "aff7cceb-3dcf-4550-bd96-de42b88e975e",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_dose": 178,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY"
  },
  {
    "bcr_patient_uuid": "e37f479f-ca05-45e4-ac6d-a974bed6e7f8",
    "patient_ID": "TCGA.CR.5243",
    "bcr_drug_barcode": "TCGA-CR-5243-D13181",
    "bcr_drug_uuid": "e2efae3f-9f4b-4c27-92a3-1e2be7112545",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_dose": 138,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "INDUCTION"
  },
  {
    "bcr_patient_uuid": "e37f479f-ca05-45e4-ac6d-a974bed6e7f8",
    "patient_ID": "TCGA.CR.5243",
    "bcr_drug_barcode": "TCGA-CR-5243-D13859",
    "bcr_drug_uuid": "cd86c95c-ee26-4743-8196-7da2d926bf5c",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 72,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_dose": 340,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "INDUCTION"
  },
  {
    "bcr_patient_uuid": "e37f479f-ca05-45e4-ac6d-a974bed6e7f8",
    "patient_ID": "TCGA.CR.5243",
    "bcr_drug_barcode": "TCGA-CR-5243-D13861",
    "bcr_drug_uuid": "a51225d1-1529-450f-804b-c19a338c24bc",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_dose": 69,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY"
  },
  {
    "bcr_patient_uuid": "692b50fc-19ca-4926-84cb-fd7168209e44",
    "patient_ID": "TCGA.CR.5247",
    "bcr_drug_barcode": "TCGA-CR-5247-D31388",
    "bcr_drug_uuid": "7d7f6836-eb8b-4b3f-99e3-8eeff2599064",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "692b50fc-19ca-4926-84cb-fd7168209e44",
    "patient_ID": "TCGA.CR.5247",
    "bcr_drug_barcode": "TCGA-CR-5247-D31389",
    "bcr_drug_uuid": "a26d314a-0f30-4458-81fa-dd201670068c",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31394",
    "bcr_drug_uuid": "fafb35af-649c-43bc-a1d1-dd6841d9accc",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31395",
    "bcr_drug_uuid": "fadf1011-af0a-4a46-8845-014a89f8cb70",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31396",
    "bcr_drug_uuid": "932949ae-1676-4692-bbae-c76a444b0da4",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31397",
    "bcr_drug_uuid": "be081099-79de-443b-a363-e03eb1e82c60",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31398",
    "bcr_drug_uuid": "6cbfc16d-513d-46ca-8d1a-503c1f252f03",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1152,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31399",
    "bcr_drug_uuid": "8D2D6687-BCF0-4537-B77D-8D5910C34325",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1152,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31400",
    "bcr_drug_uuid": "5D20FE8A-0C34-41A9-B117-2CEA2634C63D",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1152,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "a9017cd4-df30-46eb-b08f-39540b15243f",
    "patient_ID": "TCGA.CR.5248",
    "bcr_drug_barcode": "TCGA-CR-5248-D31401",
    "bcr_drug_uuid": "13733A55-6052-4149-B293-3DF87835CA00",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "IMC-A12",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1208,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "c7df3466-b9a7-4818-883b-d0cd08483570",
    "patient_ID": "TCGA.CR.5249",
    "bcr_drug_barcode": "TCGA-CR-5249-D13189",
    "bcr_drug_uuid": "94117543-5c6a-4a74-a486-0921749aca04",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e178d80-fe90-4998-9dae-726c4beceef7",
    "patient_ID": "TCGA.CR.5250",
    "bcr_drug_barcode": "TCGA-CR-5250-D13185",
    "bcr_drug_uuid": "801adc1c-a982-44df-bacc-73807239f52b",
    "form_completion_date": "2011-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_units": "MG",
    "drug_dose": 232,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY"
  },
  {
    "bcr_patient_uuid": "cd032ddb-55f2-4c77-8dcf-e4e630f7de6f",
    "patient_ID": "TCGA.CR.6470",
    "bcr_drug_barcode": "TCGA-CR-6470-D18071",
    "bcr_drug_uuid": "fea7d9ad-8a18-4f97-873f-40e33b10ddc0",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 221,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1105
  },
  {
    "bcr_patient_uuid": "cd032ddb-55f2-4c77-8dcf-e4e630f7de6f",
    "patient_ID": "TCGA.CR.6470",
    "bcr_drug_barcode": "TCGA-CR-6470-D18070",
    "bcr_drug_uuid": "e688e6f5-6601-4957-9e1c-cdfee9ae10ae",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18100",
    "bcr_drug_uuid": "b35cd9ce-a17e-41b2-b4e9-85fca91f2bef",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1129,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 40,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18098",
    "bcr_drug_uuid": "bb9aca4d-12a7-4331-a8f4-e00b84d0f2b0",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1052,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1052,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18094",
    "bcr_drug_uuid": "9fb0f015-5875-4c52-a83b-2c51e95718a7",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 548,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18099",
    "bcr_drug_uuid": "3a077e33-bbb8-4daf-bec7-830162b7a853",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1059,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1087,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18096",
    "bcr_drug_uuid": "7f4949ac-e0b8-4e8e-a9c3-f749a60cce1f",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 618,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 646,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 35,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18097",
    "bcr_drug_uuid": "f29ebd98-c46a-4e22-89e4-0a9ac9a877fd",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 618,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 646,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_dose": 1.5,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "eda29281-e803-4217-8603-d6a388408611",
    "patient_ID": "TCGA.CR.6471",
    "bcr_drug_barcode": "TCGA-CR-6471-D18095",
    "bcr_drug_uuid": "dcba766c-51f4-4eaf-8cd5-ba8d543b600f",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 548,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0956bc67-dd55-4c54-a56a-f22f2856662a",
    "patient_ID": "TCGA.CR.6472",
    "bcr_drug_barcode": "TCGA-CR-6472-D18108",
    "bcr_drug_uuid": "a7279564-0d73-4285-ae1f-23c713a4969e",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "0956bc67-dd55-4c54-a56a-f22f2856662a",
    "patient_ID": "TCGA.CR.6472",
    "bcr_drug_barcode": "TCGA-CR-6472-D18105",
    "bcr_drug_uuid": "f0aacdec-3e07-46f8-81d7-cd39c2f4377d",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "0956bc67-dd55-4c54-a56a-f22f2856662a",
    "patient_ID": "TCGA.CR.6472",
    "bcr_drug_barcode": "TCGA-CR-6472-D18106",
    "bcr_drug_uuid": "ab279cef-b39d-4001-a69c-f192e59790c4",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 9,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "0956bc67-dd55-4c54-a56a-f22f2856662a",
    "patient_ID": "TCGA.CR.6472",
    "bcr_drug_barcode": "TCGA-CR-6472-D18107",
    "bcr_drug_uuid": "0d395cb2-e707-41dc-a547-368fec44ca83",
    "form_completion_date": "2011-9-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "e8b0a499-7e9a-4f0e-b552-8e4f284141ed",
    "patient_ID": "TCGA.CR.6473",
    "bcr_drug_barcode": "TCGA-CR-6473-D18116",
    "bcr_drug_uuid": "e987a4cf-9fbe-4d81-8bce-8dca7eb4d115",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 40,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "e8b0a499-7e9a-4f0e-b552-8e4f284141ed",
    "patient_ID": "TCGA.CR.6473",
    "bcr_drug_barcode": "TCGA-CR-6473-D18114",
    "bcr_drug_uuid": "110ebb25-790c-4464-850a-14e6f1141a97",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 40,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "e8b0a499-7e9a-4f0e-b552-8e4f284141ed",
    "patient_ID": "TCGA.CR.6473",
    "bcr_drug_barcode": "TCGA-CR-6473-D18118",
    "bcr_drug_uuid": "9d049d25-e038-4a57-8060-347181f9fbb2",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "e8b0a499-7e9a-4f0e-b552-8e4f284141ed",
    "patient_ID": "TCGA.CR.6473",
    "bcr_drug_barcode": "TCGA-CR-6473-D18117",
    "bcr_drug_uuid": "b1196c02-2fd2-42ec-9fc3-8d0ed68453e1",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "9f771c36-16ec-4770-bc53-f6c861343f1c",
    "patient_ID": "TCGA.CR.6474",
    "bcr_drug_barcode": "TCGA-CR-6474-D18124",
    "bcr_drug_uuid": "62a48fc6-1cdc-4d47-919b-c728e8772363",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b74519ff-b338-45e9-9307-008223726dac",
    "patient_ID": "TCGA.CR.6477",
    "bcr_drug_barcode": "TCGA-CR-6477-D18159",
    "bcr_drug_uuid": "f1b1e2c5-f843-4269-8de3-8ed8cfcbd39e",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "b74519ff-b338-45e9-9307-008223726dac",
    "patient_ID": "TCGA.CR.6477",
    "bcr_drug_barcode": "TCGA-CR-6477-D18160",
    "bcr_drug_uuid": "6a5a4518-b29e-4637-bc94-5a4a0bd4a73f",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "b74519ff-b338-45e9-9307-008223726dac",
    "patient_ID": "TCGA.CR.6477",
    "bcr_drug_barcode": "TCGA-CR-6477-D18162",
    "bcr_drug_uuid": "d43ac0c9-4494-4a04-8d86-bb43829bd2bc",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "b74519ff-b338-45e9-9307-008223726dac",
    "patient_ID": "TCGA.CR.6477",
    "bcr_drug_barcode": "TCGA-CR-6477-D18161",
    "bcr_drug_uuid": "aa5e852a-2e06-4c43-b91a-8881353915f0",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "467d5c94-1e67-4454-9e9c-9dffaa643032",
    "patient_ID": "TCGA.CR.6478",
    "bcr_drug_barcode": "TCGA-CR-6478-D18140",
    "bcr_drug_uuid": "5967b952-2380-4f24-b6b9-7b8ae33e1a1d",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "467d5c94-1e67-4454-9e9c-9dffaa643032",
    "patient_ID": "TCGA.CR.6478",
    "bcr_drug_barcode": "TCGA-CR-6478-D18137",
    "bcr_drug_uuid": "fdbf2d41-fe89-4dd5-8a72-826df2ff8187",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "467d5c94-1e67-4454-9e9c-9dffaa643032",
    "patient_ID": "TCGA.CR.6478",
    "bcr_drug_barcode": "TCGA-CR-6478-D18138",
    "bcr_drug_uuid": "2ded5b77-8b97-49b2-b957-001608457121",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 9,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "467d5c94-1e67-4454-9e9c-9dffaa643032",
    "patient_ID": "TCGA.CR.6478",
    "bcr_drug_barcode": "TCGA-CR-6478-D18139",
    "bcr_drug_uuid": "4f5fabcf-d4a0-4bef-8a71-853602d19e67",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "ba9d4568-71a8-41fc-a2be-0bf784e36d6a",
    "patient_ID": "TCGA.CR.6480",
    "bcr_drug_barcode": "TCGA-CR-6480-D18149",
    "bcr_drug_uuid": "74a6795a-d04a-4f59-aeb8-2768a83a4dee",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "ba9d4568-71a8-41fc-a2be-0bf784e36d6a",
    "patient_ID": "TCGA.CR.6480",
    "bcr_drug_barcode": "TCGA-CR-6480-D18148",
    "bcr_drug_uuid": "eacc0c35-00b6-46a4-8ee6-d92dfd5f7646",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "ba9d4568-71a8-41fc-a2be-0bf784e36d6a",
    "patient_ID": "TCGA.CR.6480",
    "bcr_drug_barcode": "TCGA-CR-6480-D18150",
    "bcr_drug_uuid": "6d7fe68d-e479-4a41-bbf1-86df66a08e08",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "ba9d4568-71a8-41fc-a2be-0bf784e36d6a",
    "patient_ID": "TCGA.CR.6480",
    "bcr_drug_barcode": "TCGA-CR-6480-D18147",
    "bcr_drug_uuid": "0c8b45d1-877d-490f-a9bd-7018c902b064",
    "form_completion_date": "2011-9-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_dose": 270,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "9a76bd98-1d2b-4d0f-9772-883520ff6210",
    "patient_ID": "TCGA.CR.6481",
    "bcr_drug_barcode": "TCGA-CR-6481-D18171",
    "bcr_drug_uuid": "e1d10367-0f0e-4fb6-b8ec-e2914c5a0a08",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "9a76bd98-1d2b-4d0f-9772-883520ff6210",
    "patient_ID": "TCGA.CR.6481",
    "bcr_drug_barcode": "TCGA-CR-6481-D18170",
    "bcr_drug_uuid": "71b628f8-5057-4a04-b1ab-2619ade235ae",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18180",
    "bcr_drug_uuid": "36d20c27-5cb4-401a-a4b6-b5386e99d841",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18181",
    "bcr_drug_uuid": "a32b9afc-4e03-4764-8096-852dc714b1d7",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18183",
    "bcr_drug_uuid": "6c867000-4574-4f11-99ef-5e231decc673",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18185",
    "bcr_drug_uuid": "7d00a4d2-95cb-4518-8663-41791801c47b",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18184",
    "bcr_drug_uuid": "31e31610-02a7-4bc4-b391-97fc88f771d3",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18179",
    "bcr_drug_uuid": "0de72eb9-07cc-406f-a941-36f6e8cf4ece",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "468649e7-1525-4b8a-8ab5-ddb27db5f022",
    "patient_ID": "TCGA.CR.6482",
    "bcr_drug_barcode": "TCGA-CR-6482-D18182",
    "bcr_drug_uuid": "29ddfe37-3d8a-4f3b-9fe1-fa319b656b0e",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "aa10d6da-ba20-43e8-ab8f-a9b4b58738b4",
    "patient_ID": "TCGA.CR.6484",
    "bcr_drug_barcode": "TCGA-CR-6484-D18192",
    "bcr_drug_uuid": "8c0c6484-903e-44fa-b9a5-2fba8742f954",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "aa10d6da-ba20-43e8-ab8f-a9b4b58738b4",
    "patient_ID": "TCGA.CR.6484",
    "bcr_drug_barcode": "TCGA-CR-6484-D18193",
    "bcr_drug_uuid": "5ccdbbb6-6fc9-4bdb-9ba6-ac2bb647c297",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "5fce954c-11b9-41f4-9471-4b5bdc0efa7f",
    "patient_ID": "TCGA.CR.6491",
    "bcr_drug_barcode": "TCGA-CR-6491-D48386",
    "bcr_drug_uuid": "6F1DECF0-9FA8-4FB1-B012-34FE166CDE44",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5fce954c-11b9-41f4-9471-4b5bdc0efa7f",
    "patient_ID": "TCGA.CR.6491",
    "bcr_drug_barcode": "TCGA-CR-6491-D48387",
    "bcr_drug_uuid": "DEDA62B1-19CC-4414-A551-BB26684707C1",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b43b8aed-d166-4f00-8144-24ad3fe314ed",
    "patient_ID": "TCGA.CR.6493",
    "bcr_drug_barcode": "TCGA-CR-6493-D48390",
    "bcr_drug_uuid": "45240C23-AFA5-410C-BF86-CD9AE5E75F21",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b43b8aed-d166-4f00-8144-24ad3fe314ed",
    "patient_ID": "TCGA.CR.6493",
    "bcr_drug_barcode": "TCGA-CR-6493-D48391",
    "bcr_drug_uuid": "3CD427A7-86D8-4899-8A89-F9A1AFCE4570",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8fe444f-57a5-4364-ab55-09f41ecb4591",
    "patient_ID": "TCGA.CR.7365",
    "bcr_drug_barcode": "TCGA-CR-7365-D22010",
    "bcr_drug_uuid": "50c12910-84c1-463f-baeb-767591f4ae80",
    "form_completion_date": "2012-2-00",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c95de68-18d9-429b-b379-878838f88a72",
    "patient_ID": "TCGA.CR.7367",
    "bcr_drug_barcode": "TCGA-CR-7367-D31437",
    "bcr_drug_uuid": "8e48c886-230a-4206-b160-0d28143859ea",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1c95de68-18d9-429b-b379-878838f88a72",
    "patient_ID": "TCGA.CR.7367",
    "bcr_drug_barcode": "TCGA-CR-7367-D31438",
    "bcr_drug_uuid": "eddbfcb7-4642-43aa-914e-19656a954745",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "27c28c89-f4e7-4aec-a806-c0da7756e47f",
    "patient_ID": "TCGA.CR.7368",
    "bcr_drug_barcode": "TCGA-CR-7368-D31315",
    "bcr_drug_uuid": "f2d259dd-7a93-4828-93dd-c2a93ea9e5dd",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "242bdece-75dc-45b9-a9b3-3e1bc305a3e3",
    "patient_ID": "TCGA.CR.7373",
    "bcr_drug_barcode": "TCGA-CR-7373-D22019",
    "bcr_drug_uuid": "3cb4ba34-fa16-464b-9594-4b9bcf7a64fa",
    "form_completion_date": "2012-2-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "53b254b7-021f-43df-af9b-3fc01b87479e",
    "patient_ID": "TCGA.CR.7380",
    "bcr_drug_barcode": "TCGA-CR-7380-D22063",
    "bcr_drug_uuid": "fbe0eb78-08e9-4569-aecf-947cac0d6bfd",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f030e410-2585-461e-ad23-9fdf026ac06c",
    "patient_ID": "TCGA.CR.7382",
    "bcr_drug_barcode": "TCGA-CR-7382-D31300",
    "bcr_drug_uuid": "ffeae0f6-8f41-4bee-b47d-5057541e48d6",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16779eed-f386-4e8f-8475-04d33b9dd160",
    "patient_ID": "TCGA.CR.7383",
    "bcr_drug_barcode": "TCGA-CR-7383-D31295",
    "bcr_drug_uuid": "5a5fcf41-1159-447b-ab81-b1c907ecdbee",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "16779eed-f386-4e8f-8475-04d33b9dd160",
    "patient_ID": "TCGA.CR.7383",
    "bcr_drug_barcode": "TCGA-CR-7383-D31296",
    "bcr_drug_uuid": "c94ca080-9be6-4783-93e7-5136c884689a",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9f89510c-ed07-471f-b35e-7c87c237b9fe",
    "patient_ID": "TCGA.CR.7385",
    "bcr_drug_barcode": "TCGA-CR-7385-D22072",
    "bcr_drug_uuid": "25d956a8-4238-49b9-8ad9-f7345e7bcbff",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3f2e0c8a-6d5f-4763-be60-5a70994d31a1",
    "patient_ID": "TCGA.CR.7386",
    "bcr_drug_barcode": "TCGA-CR-7386-D22112",
    "bcr_drug_uuid": "b1d6f02a-a60e-4e13-abd3-21f693684a17",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3f2e0c8a-6d5f-4763-be60-5a70994d31a1",
    "patient_ID": "TCGA.CR.7386",
    "bcr_drug_barcode": "TCGA-CR-7386-D22113",
    "bcr_drug_uuid": "e4267bc2-5cd3-4cb5-824e-a070104fec90",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "511b1de1-b855-47bb-a2f8-58dc5792be47",
    "patient_ID": "TCGA.CR.7388",
    "bcr_drug_barcode": "TCGA-CR-7388-D22121",
    "bcr_drug_uuid": "410f8a74-5fb7-4ae7-9cc9-7cc310fe3f77",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "511b1de1-b855-47bb-a2f8-58dc5792be47",
    "patient_ID": "TCGA.CR.7388",
    "bcr_drug_barcode": "TCGA-CR-7388-D22124",
    "bcr_drug_uuid": "604d13bf-46bb-407f-adac-e2f80c779a9e",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 705,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 733,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "511b1de1-b855-47bb-a2f8-58dc5792be47",
    "patient_ID": "TCGA.CR.7388",
    "bcr_drug_barcode": "TCGA-CR-7388-D22120",
    "bcr_drug_uuid": "7cc6e38c-50c0-4f55-925f-060643729c57",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: INDUCTION"
  },
  {
    "bcr_patient_uuid": "511b1de1-b855-47bb-a2f8-58dc5792be47",
    "patient_ID": "TCGA.CR.7388",
    "bcr_drug_barcode": "TCGA-CR-7388-D22122",
    "bcr_drug_uuid": "3c965cbf-deea-4977-948a-84b6b2586f9c",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "511b1de1-b855-47bb-a2f8-58dc5792be47",
    "patient_ID": "TCGA.CR.7388",
    "bcr_drug_barcode": "TCGA-CR-7388-D22123",
    "bcr_drug_uuid": "ceb5f93d-3576-47c9-ae6d-398c1ddb8875",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "5422a86d-f9ff-4fb6-873e-bf7cc3de50e5",
    "patient_ID": "TCGA.CR.7389",
    "bcr_drug_barcode": "TCGA-CR-7389-D31444",
    "bcr_drug_uuid": "b376a0f8-a455-4d12-af7d-366f26231773",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5422a86d-f9ff-4fb6-873e-bf7cc3de50e5",
    "patient_ID": "TCGA.CR.7389",
    "bcr_drug_barcode": "TCGA-CR-7389-D31445",
    "bcr_drug_uuid": "dee165a1-2b0b-45ed-aab8-7f023c2ef8dd",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0f4bb968-6e10-4a86-a03e-37b61d084f31",
    "patient_ID": "TCGA.CR.7393",
    "bcr_drug_barcode": "TCGA-CR-7393-D48405",
    "bcr_drug_uuid": "E92A0F79-D2AE-45A5-8F93-D2FC5E135AD9",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -303,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0f4bb968-6e10-4a86-a03e-37b61d084f31",
    "patient_ID": "TCGA.CR.7393",
    "bcr_drug_barcode": "TCGA-CR-7393-D48406",
    "bcr_drug_uuid": "1FEEC2B3-39D9-4D4A-9F17-0D1C3711ADEC",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a40bb4bc-9ee6-4a8b-8a33-3a4ed78f69a7",
    "patient_ID": "TCGA.CR.7397",
    "bcr_drug_barcode": "TCGA-CR-7397-D48414",
    "bcr_drug_uuid": "5952F59E-E18F-4652-8F1C-60058DEEA28A",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a40bb4bc-9ee6-4a8b-8a33-3a4ed78f69a7",
    "patient_ID": "TCGA.CR.7397",
    "bcr_drug_barcode": "TCGA-CR-7397-D48415",
    "bcr_drug_uuid": "01E6303C-30A7-4178-A9AA-E2505DC4B8C3",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "91e30123-2265-4cf1-8389-f6462897837c",
    "patient_ID": "TCGA.CR.7402",
    "bcr_drug_barcode": "TCGA-CR-7402-D28765",
    "bcr_drug_uuid": "c002e09e-21e2-4eda-8436-2360bfb1f0d9",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_units": "AUC",
    "drug_dose": 1.5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "91e30123-2265-4cf1-8389-f6462897837c",
    "patient_ID": "TCGA.CR.7402",
    "bcr_drug_barcode": "TCGA-CR-7402-D28764",
    "bcr_drug_uuid": "c146e17b-6c75-4b21-9724-939a26ed21d8",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_units": "MG/M2",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PRIMARY: CONCURRENT"
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31324",
    "bcr_drug_uuid": "050b0ab3-3223-4d90-b068-8cad729354b2",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31325",
    "bcr_drug_uuid": "9c6e53db-fd86-4bbb-88d2-282ea90d125b",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31328",
    "bcr_drug_uuid": "81337c17-1592-4632-bf4c-c4025217872a",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31329",
    "bcr_drug_uuid": "6ae2d638-977f-4268-bcaf-f28c42e032ed",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31330",
    "bcr_drug_uuid": "6db87718-9327-44a3-92f3-0fe89b16b4bb",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 354,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31331",
    "bcr_drug_uuid": "af883e89-1ffa-4b40-b00c-bd0232ce8cb7",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 375,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 415,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31332",
    "bcr_drug_uuid": "fc1b59d1-7ac2-4385-896c-020d6cdf8787",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31333",
    "bcr_drug_uuid": "ff9ed268-d746-4ee3-a453-67521f65380a",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 606,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 634,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31334",
    "bcr_drug_uuid": "3fb10b09-e755-48b8-a5aa-af8ac116f134",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1052,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1080,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31335",
    "bcr_drug_uuid": "9ba61073-c6e7-43b8-b8a3-58776bd5447e",
    "form_completion_date": "2012-4-30",
    "clinical_trial_drug_classification": "PHASE I TRIAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1297,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1318,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "d189a6c6-210f-4957-b500-457d5ce3f867",
    "patient_ID": "TCGA.CR.7404",
    "bcr_drug_barcode": "TCGA-CR-7404-D31336",
    "bcr_drug_uuid": "5ca7e448-99a9-48ac-8237-bcaca6501f19",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1332,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1416,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a4fcb7fd-9c22-4486-99c5-97da050c9fb3",
    "patient_ID": "TCGA.CV.5430",
    "bcr_drug_barcode": "TCGA-CV-5430-D18730",
    "bcr_drug_uuid": "92d2595c-3bda-4b55-8b49-6bde38d97500",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1641,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1702,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a4fcb7fd-9c22-4486-99c5-97da050c9fb3",
    "patient_ID": "TCGA.CV.5430",
    "bcr_drug_barcode": "TCGA-CV-5430-D20811",
    "bcr_drug_uuid": "47f08294-0a31-49e4-8fcc-da04c9605738",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1641,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1702,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a4fcb7fd-9c22-4486-99c5-97da050c9fb3",
    "patient_ID": "TCGA.CV.5430",
    "bcr_drug_barcode": "TCGA-CV-5430-D20804",
    "bcr_drug_uuid": "da6eb296-76b5-4ff2-a086-bf5096c49af9",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1641,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1702,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "dbe29e97-f111-41d3-a25f-3b9eb9bb099f",
    "patient_ID": "TCGA.CV.5434",
    "bcr_drug_barcode": "TCGA-CV-5434-D18711",
    "bcr_drug_uuid": "2c7bc42d-27b0-4197-bdb1-346666fd7fc8",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3259,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "dbe29e97-f111-41d3-a25f-3b9eb9bb099f",
    "patient_ID": "TCGA.CV.5434",
    "bcr_drug_barcode": "TCGA-CV-5434-D20814",
    "bcr_drug_uuid": "db6629f8-e29a-4987-ac4a-89fbb505b4af",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3259,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cc23a09b-bca7-43e0-9ad0-bf272848492e",
    "patient_ID": "TCGA.CV.5435",
    "bcr_drug_barcode": "TCGA-CV-5435-D18710",
    "bcr_drug_uuid": "f790bfb0-ab34-4f22-8049-efddc91cfcc8",
    "form_completion_date": "2011-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cc23a09b-bca7-43e0-9ad0-bf272848492e",
    "patient_ID": "TCGA.CV.5435",
    "bcr_drug_barcode": "TCGA-CV-5435-D20817",
    "bcr_drug_uuid": "a02667c2-f716-40fb-9134-1af1ff3317a9",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 305,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cc23a09b-bca7-43e0-9ad0-bf272848492e",
    "patient_ID": "TCGA.CV.5435",
    "bcr_drug_barcode": "TCGA-CV-5435-D20816",
    "bcr_drug_uuid": "cda8bb55-d9e7-48a5-a6ac-a2f3bcf2f11f",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 305,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3ee863da-7991-414f-82d8-2b6502d4c061",
    "patient_ID": "TCGA.CV.5439",
    "bcr_drug_barcode": "TCGA-CV-5439-D18426",
    "bcr_drug_uuid": "f249dc8f-d9c5-421b-912e-4035f6958f41",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 345,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3ee863da-7991-414f-82d8-2b6502d4c061",
    "patient_ID": "TCGA.CV.5439",
    "bcr_drug_barcode": "TCGA-CV-5439-D20815",
    "bcr_drug_uuid": "b5acfad2-1ead-413a-9d5d-71187daf570b",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_drug_name": "IRESSA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 440,
    "drug_cycles": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "10d0a058-3e5e-4916-84c4-25f934b96f86",
    "patient_ID": "TCGA.CV.5440",
    "bcr_drug_barcode": "TCGA-CV-5440-D18428",
    "bcr_drug_uuid": "59F71D6C-9A07-4851-86B3-CFC6CAEB4F8E",
    "form_completion_date": "2011-11-4",
    "pharmaceutical_therapy_drug_name": "PALIXTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "96415324-6859-41eb-8d07-be4e6f7d9781",
    "patient_ID": "TCGA.CV.7416",
    "bcr_drug_barcode": "TCGA-CV-7416-D30340",
    "bcr_drug_uuid": "4f60858e-0dee-4741-8233-97c82f78fc23",
    "form_completion_date": "2012-4-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96415324-6859-41eb-8d07-be4e6f7d9781",
    "patient_ID": "TCGA.CV.7416",
    "bcr_drug_barcode": "TCGA-CV-7416-D30479",
    "bcr_drug_uuid": "d27d670c-8499-47eb-97a4-d36208c38885",
    "form_completion_date": "2012-4-11",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ebe99910-e9f2-43dc-ad57-ac2f610b60c8",
    "patient_ID": "TCGA.D6.6517",
    "bcr_drug_barcode": "TCGA-D6-6517-D29512",
    "bcr_drug_uuid": "7b7ee260-cb0f-4a84-b653-a73cd161391b",
    "form_completion_date": "2012-3-21",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 194,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 257,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 62.8
  },
  {
    "bcr_patient_uuid": "F248D7B9-6EA7-44EF-8AF6-8BEDA6C6BA4A",
    "patient_ID": "TCGA.D6.A6EK",
    "bcr_drug_barcode": "TCGA-D6-A6EK-D58032",
    "bcr_drug_uuid": "485A12A9-3B31-4D9C-8578-94E44D9B3427",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b4a41682-4aca-4f1d-bacd-66f5e6ec7466",
    "patient_ID": "TCGA.DQ.5624",
    "bcr_drug_barcode": "TCGA-DQ-5624-D10164",
    "bcr_drug_uuid": "4d6a624f-24c6-43bc-b0c6-0ff1a95fcbac",
    "form_completion_date": "2011-3-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 347
  },
  {
    "bcr_patient_uuid": "e95e9e7d-a1ed-46eb-9cf8-1d355bf0577f",
    "patient_ID": "TCGA.DQ.5629",
    "bcr_drug_barcode": "TCGA-DQ-5629-D10170",
    "bcr_drug_uuid": "a9862b81-7a8c-4924-bb0c-4fc5bfdb07f2",
    "form_completion_date": "2011-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 7,
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 233
  },
  {
    "bcr_patient_uuid": "10b3f56a-e61e-486b-8d3c-176668d5dc34",
    "patient_ID": "TCGA.DQ.5631",
    "bcr_drug_barcode": "TCGA-DQ-5631-D10181",
    "bcr_drug_uuid": "314dd14b-73ab-4cac-a3a4-4d1884e989d6",
    "form_completion_date": "2011-3-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "10b3f56a-e61e-486b-8d3c-176668d5dc34",
    "patient_ID": "TCGA.DQ.5631",
    "bcr_drug_barcode": "TCGA-DQ-5631-D10207",
    "bcr_drug_uuid": "595d30e2-cfc0-4838-9f6a-fa554ffef774",
    "form_completion_date": "2011-4-11",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 475,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 518,
    "drug_cycles": 2,
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 965
  },
  {
    "bcr_patient_uuid": "10b3f56a-e61e-486b-8d3c-176668d5dc34",
    "patient_ID": "TCGA.DQ.5631",
    "bcr_drug_barcode": "TCGA-DQ-5631-D10186",
    "bcr_drug_uuid": "112bfa41-a80c-4e54-87af-a3901a5460ce",
    "form_completion_date": "2011-4-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 475,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 518,
    "drug_cycles": 2,
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 577
  },
  {
    "bcr_patient_uuid": "8a3fdb52-63ef-48d7-95ff-167829825eb9",
    "patient_ID": "TCGA.DQ.7588",
    "bcr_drug_barcode": "TCGA-DQ-7588-D29656",
    "bcr_drug_uuid": "922a9236-5a21-4d87-9254-029e49d73400",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8a3fdb52-63ef-48d7-95ff-167829825eb9",
    "patient_ID": "TCGA.DQ.7588",
    "bcr_drug_barcode": "TCGA-DQ-7588-D29659",
    "bcr_drug_uuid": "a4fc4d60-02bd-4010-8177-6381336de8b2",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "AT-101",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "drug_cycles": 3,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "8a3fdb52-63ef-48d7-95ff-167829825eb9",
    "patient_ID": "TCGA.DQ.7588",
    "bcr_drug_barcode": "TCGA-DQ-7588-D29657",
    "bcr_drug_uuid": "c7d3e770-c361-4aba-8224-7c6ee68727f9",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 152,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 455
  },
  {
    "bcr_patient_uuid": "8a3fdb52-63ef-48d7-95ff-167829825eb9",
    "patient_ID": "TCGA.DQ.7588",
    "bcr_drug_barcode": "TCGA-DQ-7588-D29655",
    "bcr_drug_uuid": "42b21926-1ab0-4056-a3d7-710daa53c9d2",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8a3fdb52-63ef-48d7-95ff-167829825eb9",
    "patient_ID": "TCGA.DQ.7588",
    "bcr_drug_barcode": "TCGA-DQ-7588-D29660",
    "bcr_drug_uuid": "524d4fd7-aece-41b3-9cf6-962290779c47",
    "form_completion_date": "2012-3-27",
    "pharmaceutical_therapy_drug_name": "AT-101",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 421,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 425,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "4648225e-5b68-488a-969a-e8d812190c6f",
    "patient_ID": "TCGA.DQ.7589",
    "bcr_drug_barcode": "TCGA-DQ-7589-D33012",
    "bcr_drug_uuid": "a4180d87-8158-4da3-8ee9-c3e8e2e373ef",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4648225e-5b68-488a-969a-e8d812190c6f",
    "patient_ID": "TCGA.DQ.7589",
    "bcr_drug_barcode": "TCGA-DQ-7589-D33013",
    "bcr_drug_uuid": "0d61b8e3-b176-42f3-b99b-fff69007fd9a",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4648225e-5b68-488a-969a-e8d812190c6f",
    "patient_ID": "TCGA.DQ.7589",
    "bcr_drug_barcode": "TCGA-DQ-7589-D33014",
    "bcr_drug_uuid": "6e256d49-b28d-4a32-9d14-20a9f02755a2",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4648225e-5b68-488a-969a-e8d812190c6f",
    "patient_ID": "TCGA.DQ.7589",
    "bcr_drug_barcode": "TCGA-DQ-7589-D33015",
    "bcr_drug_uuid": "35bec474-aed7-466b-a515-ff6126d3c5be",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4648225e-5b68-488a-969a-e8d812190c6f",
    "patient_ID": "TCGA.DQ.7589",
    "bcr_drug_barcode": "TCGA-DQ-7589-D33016",
    "bcr_drug_uuid": "3d9261b2-d77c-4e21-9243-13ba42d7747f",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8a391ba-e595-4a91-bd55-02b312e55427",
    "patient_ID": "TCGA.DQ.7590",
    "bcr_drug_barcode": "TCGA-DQ-7590-D33020",
    "bcr_drug_uuid": "5acafa10-e370-4aca-8f29-bcfb2eb86e4a",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a8a391ba-e595-4a91-bd55-02b312e55427",
    "patient_ID": "TCGA.DQ.7590",
    "bcr_drug_barcode": "TCGA-DQ-7590-D33021",
    "bcr_drug_uuid": "c2cd31df-7cdc-4229-b365-dadb03887c0d",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3ef779cf-772e-445e-93c8-e1094ea8b878",
    "patient_ID": "TCGA.DQ.7591",
    "bcr_drug_barcode": "TCGA-DQ-7591-D29640",
    "bcr_drug_uuid": "3ace2e6d-80b1-4989-9b9a-6976ddc1fc72",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/WK",
    "drug_tota_dose_units": "MG",
    "drug_dose": 83,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 664
  },
  {
    "bcr_patient_uuid": "3ef779cf-772e-445e-93c8-e1094ea8b878",
    "patient_ID": "TCGA.DQ.7591",
    "bcr_drug_barcode": "TCGA-DQ-7591-D29643",
    "bcr_drug_uuid": "edb39596-25dd-481d-9cbf-62cf35d84a18",
    "form_completion_date": "2012-2-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/WK",
    "drug_tota_dose_units": "MG",
    "drug_dose": 56,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 448
  },
  {
    "bcr_patient_uuid": "d82e6c52-9ea4-4f60-989c-cf95d464fd6f",
    "patient_ID": "TCGA.DQ.7592",
    "bcr_drug_barcode": "TCGA-DQ-7592-D29651",
    "bcr_drug_uuid": "8b821505-2057-4d3c-a55e-c9031f05c315",
    "form_completion_date": "2012-2-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/WK",
    "drug_tota_dose_units": "MG",
    "drug_dose": 65,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 455
  },
  {
    "bcr_patient_uuid": "67eae8b3-3bd2-4e87-af78-ffe8221f318d",
    "patient_ID": "TCGA.DQ.7593",
    "bcr_drug_barcode": "TCGA-DQ-7593-D33035",
    "bcr_drug_uuid": "ba7fced5-d534-490e-8041-ddd95e8df92b",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67eae8b3-3bd2-4e87-af78-ffe8221f318d",
    "patient_ID": "TCGA.DQ.7593",
    "bcr_drug_barcode": "TCGA-DQ-7593-D33036",
    "bcr_drug_uuid": "15a3c061-b666-4dbf-916a-fcbf82997a5b",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62ca707c-0657-4b7c-863c-99f4ec475972",
    "patient_ID": "TCGA.DQ.7594",
    "bcr_drug_barcode": "TCGA-DQ-7594-D33041",
    "bcr_drug_uuid": "30e4d1cd-f366-44fc-8a63-d3e0375fa382",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62ca707c-0657-4b7c-863c-99f4ec475972",
    "patient_ID": "TCGA.DQ.7594",
    "bcr_drug_barcode": "TCGA-DQ-7594-D33042",
    "bcr_drug_uuid": "77f5ce85-f72e-4ba3-9d07-3fc43549d753",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f6ebe511-a4df-4310-bd59-3a46d43f100b",
    "patient_ID": "TCGA.DQ.7595",
    "bcr_drug_barcode": "TCGA-DQ-7595-D33046",
    "bcr_drug_uuid": "fca19bda-16e6-464d-892e-478bcd016b6d",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0f25d7fd-fc7c-4563-a8bd-80b5e0c32ea2",
    "patient_ID": "TCGA.DQ.7596",
    "bcr_drug_barcode": "TCGA-DQ-7596-D33026",
    "bcr_drug_uuid": "A2B77C67-79C9-4899-89F0-63316D7139FE",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0f25d7fd-fc7c-4563-a8bd-80b5e0c32ea2",
    "patient_ID": "TCGA.DQ.7596",
    "bcr_drug_barcode": "TCGA-DQ-7596-D33028",
    "bcr_drug_uuid": "C7272631-BBBE-4109-BBF2-2A1F12F340AD",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0f25d7fd-fc7c-4563-a8bd-80b5e0c32ea2",
    "patient_ID": "TCGA.DQ.7596",
    "bcr_drug_barcode": "TCGA-DQ-7596-D33029",
    "bcr_drug_uuid": "927CC806-EB90-47AC-A80F-A6631E1FC388",
    "form_completion_date": "2012-7-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 266,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "15E43EE8-3080-4895-84FB-A24AD3A68B97",
    "patient_ID": "TCGA.F7.A50J",
    "bcr_drug_barcode": "TCGA-F7-A50J-D49371",
    "bcr_drug_uuid": "27B33D55-BFC3-47A5-8C02-6D8441EA9F55",
    "form_completion_date": "2013-9-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f090838e-7cc0-4ba8-b3a2-faaa99743785",
    "patient_ID": "TCGA.H7.8501",
    "bcr_drug_barcode": "TCGA-H7-8501-D45206",
    "bcr_drug_uuid": "CE59C44C-095C-4C81-90DD-BC9E40E23C2F",
    "form_completion_date": "2013-7-10",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "ce603d46-299a-4ffb-84ab-b3b914a561b9",
    "patient_ID": "TCGA.H7.8502",
    "bcr_drug_barcode": "TCGA-H7-8502-D34530",
    "bcr_drug_uuid": "29CBDADF-BF68-43DD-9DC3-917E98F13DDB",
    "form_completion_date": "2012-8-21",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108
  },
  {
    "bcr_patient_uuid": "EBFB8C1B-471F-4ACB-A1FE-287E02CADBA7",
    "patient_ID": "TCGA.H7.A6C4",
    "bcr_drug_barcode": "TCGA-H7-A6C4-D52043",
    "bcr_drug_uuid": "C9C7CB40-30B9-4383-A2E0-7972E9914041",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "EBFB8C1B-471F-4ACB-A1FE-287E02CADBA7",
    "patient_ID": "TCGA.H7.A6C4",
    "bcr_drug_barcode": "TCGA-H7-A6C4-D52044",
    "bcr_drug_uuid": "0F0597F1-75B8-449A-BBFB-E6C6A65DF58B",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EBFB8C1B-471F-4ACB-A1FE-287E02CADBA7",
    "patient_ID": "TCGA.H7.A6C4",
    "bcr_drug_barcode": "TCGA-H7-A6C4-D52046",
    "bcr_drug_uuid": "48D634EA-A71B-4D0A-AFF3-BD9490F2C76E",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64307",
    "bcr_drug_uuid": "BB83B157-EA50-4A0B-94B6-2E81613D9A43",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64308",
    "bcr_drug_uuid": "967D6EAB-B5EE-47E6-B5B1-F99FA3289CA5",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64309",
    "bcr_drug_uuid": "E8E602C2-DFE5-45EC-BFA6-C20058005828",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64310",
    "bcr_drug_uuid": "15A8D8D6-99D9-46CF-B88D-29C97991D2C7",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64311",
    "bcr_drug_uuid": "2A72E5DE-3D94-41EA-A33D-C6ED26D8A9C2",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5c48e21f-1fe9-4007-9b0c-7ca766586fff",
    "patient_ID": "TCGA.HD.7229",
    "bcr_drug_barcode": "TCGA-HD-7229-D64312",
    "bcr_drug_uuid": "86DDF2DE-FA13-426F-80AC-325EB7A10A02",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "5-FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 187,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e8ac39e6-377a-412c-b18d-f6c4fc654ec6",
    "patient_ID": "TCGA.HD.7753",
    "bcr_drug_barcode": "TCGA-HD-7753-D64315",
    "bcr_drug_uuid": "69A92CC1-BEF7-4E0B-8305-F98D83B905C9",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 85,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "43b99616-d7b4-404e-8912-4275f8d6dc55",
    "patient_ID": "TCGA.HD.8224",
    "bcr_drug_barcode": "TCGA-HD-8224-D51231",
    "bcr_drug_uuid": "78079EB9-5B8A-4EB2-A11B-32931552F7F7",
    "form_completion_date": "2013-11-13",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f1b7b418-80d2-4ddf-94cd-f79abba0a2a4",
    "patient_ID": "TCGA.HD.8314",
    "bcr_drug_barcode": "TCGA-HD-8314-D64326",
    "bcr_drug_uuid": "01833303-65F6-411B-BE41-32AEADD47BDA",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9d469689-0413-4898-aa83-c6756cbfe117",
    "patient_ID": "TCGA.HL.7533",
    "bcr_drug_barcode": "TCGA-HL-7533-D48759",
    "bcr_drug_uuid": "E2C4D622-6D31-49C1-B697-B920B4734CFD",
    "form_completion_date": "2013-9-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9d469689-0413-4898-aa83-c6756cbfe117",
    "patient_ID": "TCGA.HL.7533",
    "bcr_drug_barcode": "TCGA-HL-7533-D48760",
    "bcr_drug_uuid": "F5D122A1-281B-4BAB-9B1B-0DCDC88619EB",
    "form_completion_date": "2013-9-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9d469689-0413-4898-aa83-c6756cbfe117",
    "patient_ID": "TCGA.HL.7533",
    "bcr_drug_barcode": "TCGA-HL-7533-D48761",
    "bcr_drug_uuid": "A3A1EBF1-F125-413D-9A93-EB84F44577A2",
    "form_completion_date": "2013-9-20",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ebd1be2c-35ca-45c0-9aba-9baf432114c1",
    "patient_ID": "TCGA.IQ.7630",
    "bcr_drug_barcode": "TCGA-IQ-7630-D38966",
    "bcr_drug_uuid": "62308BC2-5EC2-453B-B7AD-BDBC560EEFA3",
    "form_completion_date": "2013-1-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ebd1be2c-35ca-45c0-9aba-9baf432114c1",
    "patient_ID": "TCGA.IQ.7630",
    "bcr_drug_barcode": "TCGA-IQ-7630-D38968",
    "bcr_drug_uuid": "02C628D8-7F10-4179-939A-9BE508E45F66",
    "form_completion_date": "2013-1-7",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D3F786A6-5D72-4D6E-85FD-0C6ADE9F6E95",
    "patient_ID": "TCGA.IQ.A61E",
    "bcr_drug_barcode": "TCGA-IQ-A61E-D45794",
    "bcr_drug_uuid": "A1EDB1AA-E75C-4E38-97F4-AEBF97E969C5",
    "form_completion_date": "2013-7-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C512BA69-7B90-4334-92EB-48AB91AA05F2",
    "patient_ID": "TCGA.IQ.A61G",
    "bcr_drug_barcode": "TCGA-IQ-A61G-D46116",
    "bcr_drug_uuid": "1AC89840-C432-4BFB-B6FA-8F59B585E207",
    "form_completion_date": "2013-8-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D69E29CA-24BE-4F35-A581-F82E624B8E8B",
    "patient_ID": "TCGA.IQ.A61J",
    "bcr_drug_barcode": "TCGA-IQ-A61J-D45953",
    "bcr_drug_uuid": "EF73E5A4-D9DF-4B59-914F-B55699E32444",
    "form_completion_date": "2013-7-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2C96D3C4-323E-4A2A-9132-40E860B701A5",
    "patient_ID": "TCGA.IQ.A61K",
    "bcr_drug_barcode": "TCGA-IQ-A61K-D46027",
    "bcr_drug_uuid": "F14AA026-A12F-4F54-860C-4357B6BCE71E",
    "form_completion_date": "2013-7-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "818AD88A-131E-49DF-85D8-55BBA0E9EC02",
    "patient_ID": "TCGA.IQ.A61L",
    "bcr_drug_barcode": "TCGA-IQ-A61L-D46037",
    "bcr_drug_uuid": "CB9E8E78-5F55-47E8-AFE7-6DBFBBDF2F6D",
    "form_completion_date": "2013-7-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "818AD88A-131E-49DF-85D8-55BBA0E9EC02",
    "patient_ID": "TCGA.IQ.A61L",
    "bcr_drug_barcode": "TCGA-IQ-A61L-D46038",
    "bcr_drug_uuid": "3F0E83AD-CCC8-4D38-A2EC-9F7434E4ABFE",
    "form_completion_date": "2013-7-29",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B835289F-6174-4BF9-AEDF-9EBB9EF4EB62",
    "patient_ID": "TCGA.IQ.A61O",
    "bcr_drug_barcode": "TCGA-IQ-A61O-D46113",
    "bcr_drug_uuid": "4C230DB3-D647-4B7B-8BA6-D932229055CA",
    "form_completion_date": "2013-8-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ABBCC1D8-AB74-4459-BF28-CC627BEF440E",
    "patient_ID": "TCGA.KU.A6H7",
    "bcr_drug_barcode": "TCGA-KU-A6H7-D49035",
    "bcr_drug_uuid": "11C1650F-C510-4D0F-B3A0-457643D343A3",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9BF40EEB-9A87-44A2-A782-197AB954C937",
    "patient_ID": "TCGA.KU.A6H8",
    "bcr_drug_barcode": "TCGA-KU-A6H8-D49028",
    "bcr_drug_uuid": "1FF745F6-3C00-419C-A325-A31DC3EC5950",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9BF40EEB-9A87-44A2-A782-197AB954C937",
    "patient_ID": "TCGA.KU.A6H8",
    "bcr_drug_barcode": "TCGA-KU-A6H8-D54127",
    "bcr_drug_uuid": "5B00B1C9-A489-4C6F-BEBF-226F6D522440",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9BF40EEB-9A87-44A2-A782-197AB954C937",
    "patient_ID": "TCGA.KU.A6H8",
    "bcr_drug_barcode": "TCGA-KU-A6H8-D54128",
    "bcr_drug_uuid": "1AFE9E4F-E16A-45B4-BFF4-4120AAEDF4FD",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7BFEF2DD-5F82-4521-9369-0329E41FAF1B",
    "patient_ID": "TCGA.MT.A67G",
    "bcr_drug_barcode": "TCGA-MT-A67G-D43419",
    "bcr_drug_uuid": "6FB3B336-3A3D-4D3C-A0C4-F193A670CAAF",
    "form_completion_date": "2013-5-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FD7E2226-8086-4A56-867B-6457B87A7FED",
    "patient_ID": "TCGA.MZ.A5BI",
    "bcr_drug_barcode": "TCGA-MZ-A5BI-D62978",
    "bcr_drug_uuid": "B2A96D32-1EE5-4A57-9353-DA3D56C909D7",
    "form_completion_date": "2014-7-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AAD9A83A-AB62-47B0-990C-527CCDB58D63",
    "patient_ID": "TCGA.MZ.A6I9",
    "bcr_drug_barcode": "TCGA-MZ-A6I9-D59252",
    "bcr_drug_uuid": "009B15C8-A754-424F-A9A6-9E2573853865",
    "form_completion_date": "2014-5-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AAD9A83A-AB62-47B0-990C-527CCDB58D63",
    "patient_ID": "TCGA.MZ.A6I9",
    "bcr_drug_barcode": "TCGA-MZ-A6I9-D59260",
    "bcr_drug_uuid": "6D70EFC4-55DF-4730-8AD2-FBF6389BB96D",
    "form_completion_date": "2014-5-7",
    "pharmaceutical_therapy_drug_name": "RIGOSERTIB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 365,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AAD9A83A-AB62-47B0-990C-527CCDB58D63",
    "patient_ID": "TCGA.MZ.A6I9",
    "bcr_drug_barcode": "TCGA-MZ-A6I9-D59279",
    "bcr_drug_uuid": "13A3859B-54D8-498C-B246-493D8E7F98BA",
    "form_completion_date": "2014-5-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 449,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 449,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AAD9A83A-AB62-47B0-990C-527CCDB58D63",
    "patient_ID": "TCGA.MZ.A6I9",
    "bcr_drug_barcode": "TCGA-MZ-A6I9-D59281",
    "bcr_drug_uuid": "EB54E219-0F65-4571-A9D3-4A501BAB7642",
    "form_completion_date": "2014-5-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 449,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 449,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06580CBC-D0D8-4B97-87EF-EBC17CDAE81C",
    "patient_ID": "TCGA.MZ.A7D7",
    "bcr_drug_barcode": "TCGA-MZ-A7D7-D56165",
    "bcr_drug_uuid": "46EE99A3-9055-49CB-85CC-5E710923DCC3",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06580CBC-D0D8-4B97-87EF-EBC17CDAE81C",
    "patient_ID": "TCGA.MZ.A7D7",
    "bcr_drug_barcode": "TCGA-MZ-A7D7-D68545",
    "bcr_drug_uuid": "60DA6BFD-F3C6-4F84-83D2-6E0757B17DEA",
    "form_completion_date": "2014-12-26",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 526,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "06580CBC-D0D8-4B97-87EF-EBC17CDAE81C",
    "patient_ID": "TCGA.MZ.A7D7",
    "bcr_drug_barcode": "TCGA-MZ-A7D7-D68544",
    "bcr_drug_uuid": "2D46D5D9-AA58-415D-9AA6-F46A32CBF169",
    "form_completion_date": "2014-12-26",
    "pharmaceutical_therapy_drug_name": "ERIBULIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 526,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "451E4916-80EE-45F8-AD70-84340868A5A9",
    "patient_ID": "TCGA.P3.A5Q6",
    "bcr_drug_barcode": "TCGA-P3-A5Q6-D43799",
    "bcr_drug_uuid": "83FE780B-5F32-4B47-ABE0-E710B2CD1AC0",
    "form_completion_date": "2013-6-4",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "451E4916-80EE-45F8-AD70-84340868A5A9",
    "patient_ID": "TCGA.P3.A5Q6",
    "bcr_drug_barcode": "TCGA-P3-A5Q6-D43798",
    "bcr_drug_uuid": "B71ADE8C-6A2D-45B7-B690-2BF5B3F111F5",
    "form_completion_date": "2013-6-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4587AE9F-71FB-4582-82FF-FB407FEE6445",
    "patient_ID": "TCGA.P3.A5QF",
    "bcr_drug_barcode": "TCGA-P3-A5QF-D43805",
    "bcr_drug_uuid": "C5527910-F24A-4DF1-A793-F481B2570F78",
    "form_completion_date": "2013-6-4",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3A2FE6DA-5F3C-4AD8-B735-23ADFFE3FD6B",
    "patient_ID": "TCGA.P3.A6SW",
    "bcr_drug_barcode": "TCGA-P3-A6SW-D50087",
    "bcr_drug_uuid": "90C42460-FDE6-4995-AC15-978C9B51A501",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "220D75AE-C94B-473A-A988-AC40C15FA219",
    "patient_ID": "TCGA.P3.A6SX",
    "bcr_drug_barcode": "TCGA-P3-A6SX-D50091",
    "bcr_drug_uuid": "27CBE591-5B5B-4E08-9BA9-56385546BD37",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A563109D-0990-4BDC-8BD7-6766D1EADBDC",
    "patient_ID": "TCGA.P3.A6T2",
    "bcr_drug_barcode": "TCGA-P3-A6T2-D50101",
    "bcr_drug_uuid": "B134B856-27DA-4175-8AEF-8BEFC4CE09B8",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "13E936FF-81F0-49B9-BC2E-2EA43921F450",
    "patient_ID": "TCGA.P3.A6T3",
    "bcr_drug_barcode": "TCGA-P3-A6T3-D50143",
    "bcr_drug_uuid": "5FBB121D-7484-4EDC-B9D8-531A410C194D",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "91D44093-D8D9-442C-92ED-E659C45B4E0A",
    "patient_ID": "TCGA.P3.A6T6",
    "bcr_drug_barcode": "TCGA-P3-A6T6-D50156",
    "bcr_drug_uuid": "B47DEFB6-7DE6-45BF-88AB-2A193171149F",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "91D44093-D8D9-442C-92ED-E659C45B4E0A",
    "patient_ID": "TCGA.P3.A6T6",
    "bcr_drug_barcode": "TCGA-P3-A6T6-D50157",
    "bcr_drug_uuid": "ED4A1471-8B9D-40FA-86E0-EF1C08EADB26",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7CB42865-AF55-487D-B604-FAACE62BBA51",
    "patient_ID": "TCGA.P3.A6T7",
    "bcr_drug_barcode": "TCGA-P3-A6T7-D50172",
    "bcr_drug_uuid": "17CE025C-47EF-4C35-B1AA-551D7B71D8A6",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F1B904E-39A7-4870-B0F4-EFA1D43E50A8",
    "patient_ID": "TCGA.P3.A6T8",
    "bcr_drug_barcode": "TCGA-P3-A6T8-D50176",
    "bcr_drug_uuid": "931DA439-B763-4E21-BC67-2AC0E0FFD033",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22AE99B4-52CF-4D20-A068-7457E16919B6",
    "patient_ID": "TCGA.QK.A6IF",
    "bcr_drug_barcode": "TCGA-QK-A6IF-D48967",
    "bcr_drug_uuid": "D07A6E9C-1FC4-4110-A6C8-E48562632703",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "22AE99B4-52CF-4D20-A068-7457E16919B6",
    "patient_ID": "TCGA.QK.A6IF",
    "bcr_drug_barcode": "TCGA-QK-A6IF-D54877",
    "bcr_drug_uuid": "4910BF75-4B3C-44EA-8EC9-1567B5AAA6E7",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3203D0AE-5FE9-4FF2-BE0A-1D97F7684819",
    "patient_ID": "TCGA.QK.A6IG",
    "bcr_drug_barcode": "TCGA-QK-A6IG-D48980",
    "bcr_drug_uuid": "15D66913-F58A-49F3-B1C6-26BBEBE16A27",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3203D0AE-5FE9-4FF2-BE0A-1D97F7684819",
    "patient_ID": "TCGA.QK.A6IG",
    "bcr_drug_barcode": "TCGA-QK-A6IG-D54916",
    "bcr_drug_uuid": "D8A6EDE4-2CF3-4796-8B5C-0CBC47C2817C",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1F286F6-D4A1-494A-88C8-FF8E2A3DF2CE",
    "patient_ID": "TCGA.QK.A6IH",
    "bcr_drug_barcode": "TCGA-QK-A6IH-D48993",
    "bcr_drug_uuid": "34F872C4-F666-475A-8F59-505BAF0D5C35",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1F286F6-D4A1-494A-88C8-FF8E2A3DF2CE",
    "patient_ID": "TCGA.QK.A6IH",
    "bcr_drug_barcode": "TCGA-QK-A6IH-D54921",
    "bcr_drug_uuid": "00D9CF82-0A61-40A4-AAE9-A575F284A82A",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1F286F6-D4A1-494A-88C8-FF8E2A3DF2CE",
    "patient_ID": "TCGA.QK.A6IH",
    "bcr_drug_barcode": "TCGA-QK-A6IH-D66626",
    "bcr_drug_uuid": "3774462C-1318-453E-AC1C-BA0773F7D228",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1F286F6-D4A1-494A-88C8-FF8E2A3DF2CE",
    "patient_ID": "TCGA.QK.A6IH",
    "bcr_drug_barcode": "TCGA-QK-A6IH-D66628",
    "bcr_drug_uuid": "184CB90B-679D-49AD-BA58-9D154511A26D",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1F286F6-D4A1-494A-88C8-FF8E2A3DF2CE",
    "patient_ID": "TCGA.QK.A6IH",
    "bcr_drug_barcode": "TCGA-QK-A6IH-D66631",
    "bcr_drug_uuid": "A69AB28B-73B3-4939-AEA7-8E28FA2E7BAA",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AEA4CF5-ADE6-4747-B1D1-C431564F5FA6",
    "patient_ID": "TCGA.QK.A6II",
    "bcr_drug_barcode": "TCGA-QK-A6II-D49014",
    "bcr_drug_uuid": "A4738C8D-9E4F-4B14-8E83-5928D179CB6A",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AEA4CF5-ADE6-4747-B1D1-C431564F5FA6",
    "patient_ID": "TCGA.QK.A6II",
    "bcr_drug_barcode": "TCGA-QK-A6II-D66694",
    "bcr_drug_uuid": "4D656185-33C7-49CB-B9C7-78A4DD88EE23",
    "form_completion_date": "2014-10-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AEA4CF5-ADE6-4747-B1D1-C431564F5FA6",
    "patient_ID": "TCGA.QK.A6II",
    "bcr_drug_barcode": "TCGA-QK-A6II-D66697",
    "bcr_drug_uuid": "496E7790-5648-4031-8700-B1B8DE9B9A0D",
    "form_completion_date": "2014-10-22",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AEA4CF5-ADE6-4747-B1D1-C431564F5FA6",
    "patient_ID": "TCGA.QK.A6II",
    "bcr_drug_barcode": "TCGA-QK-A6II-D66701",
    "bcr_drug_uuid": "BA82D367-59CA-4E0C-A97C-10CEB28623A6",
    "form_completion_date": "2014-10-22",
    "pharmaceutical_therapy_drug_name": "ERBITUX",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2C878227-77A1-4988-A46C-885DB9E400F7",
    "patient_ID": "TCGA.QK.A8Z7",
    "bcr_drug_barcode": "TCGA-QK-A8Z7-D63234",
    "bcr_drug_uuid": "9ADF32C7-F5CA-4A84-AD80-CB89A18B3ABA",
    "form_completion_date": "2014-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2C878227-77A1-4988-A46C-885DB9E400F7",
    "patient_ID": "TCGA.QK.A8Z7",
    "bcr_drug_barcode": "TCGA-QK-A8Z7-D63235",
    "bcr_drug_uuid": "51B88D02-9EEE-49D3-8FB7-DA50B9A64A25",
    "form_completion_date": "2014-8-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AC511727-185B-4AC0-B6C0-DC3A79657BE6",
    "patient_ID": "TCGA.QK.A8Z8",
    "bcr_drug_barcode": "TCGA-QK-A8Z8-D58555",
    "bcr_drug_uuid": "3B628E0F-5450-40B6-9AFC-74089147F0CE",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AC511727-185B-4AC0-B6C0-DC3A79657BE6",
    "patient_ID": "TCGA.QK.A8Z8",
    "bcr_drug_barcode": "TCGA-QK-A8Z8-D58556",
    "bcr_drug_uuid": "692C8635-41A2-4E05-B2D5-F946DA23A230",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AC511727-185B-4AC0-B6C0-DC3A79657BE6",
    "patient_ID": "TCGA.QK.A8Z8",
    "bcr_drug_barcode": "TCGA-QK-A8Z8-D58558",
    "bcr_drug_uuid": "4540AF1A-FB4C-479D-8FA3-ADAAD2358055",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8980FB06-E38D-459F-A777-52048D492DEF",
    "patient_ID": "TCGA.QK.A8Z9",
    "bcr_drug_barcode": "TCGA-QK-A8Z9-D58569",
    "bcr_drug_uuid": "28AACA3B-F335-40D2-8947-6C8AF80A6707",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8980FB06-E38D-459F-A777-52048D492DEF",
    "patient_ID": "TCGA.QK.A8Z9",
    "bcr_drug_barcode": "TCGA-QK-A8Z9-D58570",
    "bcr_drug_uuid": "A9932136-BD96-46A5-B4AC-1DA523473034",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8980FB06-E38D-459F-A777-52048D492DEF",
    "patient_ID": "TCGA.QK.A8Z9",
    "bcr_drug_barcode": "TCGA-QK-A8Z9-D67697",
    "bcr_drug_uuid": "9AA6720E-3B6D-4446-81B7-E469AE00ADF4",
    "form_completion_date": "2014-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 302,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8980FB06-E38D-459F-A777-52048D492DEF",
    "patient_ID": "TCGA.QK.A8Z9",
    "bcr_drug_barcode": "TCGA-QK-A8Z9-D67732",
    "bcr_drug_uuid": "47D68D99-87A9-44E5-A131-A5D7758873C9",
    "form_completion_date": "2014-11-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 302,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86A5C819-49E9-4B06-B43D-0F0C06A935FD",
    "patient_ID": "TCGA.QK.A8ZA",
    "bcr_drug_barcode": "TCGA-QK-A8ZA-D58573",
    "bcr_drug_uuid": "810E071C-2BDB-4F0B-AD71-D043F4E6864A",
    "form_completion_date": "2014-4-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09F6C3AB-B799-404A-B301-22B9CAF33E82",
    "patient_ID": "TCGA.QK.AA3K",
    "bcr_drug_barcode": "TCGA-QK-AA3K-D60423",
    "bcr_drug_uuid": "9248E69A-EE96-450F-9065-EDDA623DD206",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B815FAE9-C595-4C76-ACC6-6D38B9AF9578",
    "patient_ID": "TCGA.RS.A6TO",
    "bcr_drug_barcode": "TCGA-RS-A6TO-D57157",
    "bcr_drug_uuid": "4C52111A-C482-474B-A76A-E10E8346E244",
    "form_completion_date": "2014-3-10",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B9E81DA-EA22-4F6A-BDB1-281B0EC8A451",
    "patient_ID": "TCGA.T2.A6WX",
    "bcr_drug_barcode": "TCGA-T2-A6WX-D50752",
    "bcr_drug_uuid": "B9E77C04-E6CA-4FEF-B4F4-2188EEE920DD",
    "form_completion_date": "2013-10-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B9E81DA-EA22-4F6A-BDB1-281B0EC8A451",
    "patient_ID": "TCGA.T2.A6WX",
    "bcr_drug_barcode": "TCGA-T2-A6WX-D50753",
    "bcr_drug_uuid": "DD3FD6F9-5E1B-492B-9188-E3787EF58B65",
    "form_completion_date": "2013-10-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B9E81DA-EA22-4F6A-BDB1-281B0EC8A451",
    "patient_ID": "TCGA.T2.A6WX",
    "bcr_drug_barcode": "TCGA-T2-A6WX-D50754",
    "bcr_drug_uuid": "8466B93A-61FF-4DA0-8E3E-79BF58ED4414",
    "form_completion_date": "2013-10-30",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93CBDA0F-8454-4127-A6DA-A19DDA345DEB",
    "patient_ID": "TCGA.T2.A6WZ",
    "bcr_drug_barcode": "TCGA-T2-A6WZ-D50293",
    "bcr_drug_uuid": "B1E26606-2BEE-4A12-AFF8-5D503576D0C1",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "PX-866",
    "clinical_trial_drug_classification": "PI3K INHIBITOR",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "93CBDA0F-8454-4127-A6DA-A19DDA345DEB",
    "patient_ID": "TCGA.T2.A6WZ",
    "bcr_drug_barcode": "TCGA-T2-A6WZ-D50299",
    "bcr_drug_uuid": "1338CC83-0121-4F93-A0D2-2C4D9D09A8BE",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "93CBDA0F-8454-4127-A6DA-A19DDA345DEB",
    "patient_ID": "TCGA.T2.A6WZ",
    "bcr_drug_barcode": "TCGA-T2-A6WZ-D50327",
    "bcr_drug_uuid": "03FF8C25-E9D2-48DB-B0B7-91EB1EDDB840",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FF38628E-8ABE-44D6-8D3B-7CFE46BD2E35",
    "patient_ID": "TCGA.T2.A6X0",
    "bcr_drug_barcode": "TCGA-T2-A6X0-D49735",
    "bcr_drug_uuid": "FC96B3A3-F5E0-44D7-B386-042B36E43162",
    "form_completion_date": "2013-10-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B3DBF9AD-9602-4E44-BEAC-1CFA5F8BBA5D",
    "patient_ID": "TCGA.TN.A7HJ",
    "bcr_drug_barcode": "TCGA-TN-A7HJ-D65225",
    "bcr_drug_uuid": "A1722FCD-DE8D-4C67-AAD0-56F66AC25A07",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4B50AEA4-4AD1-4BF6-9CF1-984C28A99C84",
    "patient_ID": "TCGA.TN.A7HL",
    "bcr_drug_barcode": "TCGA-TN-A7HL-D65230",
    "bcr_drug_uuid": "B3AB0570-937F-45FD-9E04-FD0041693492",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "545C9F09-DF14-4302-B131-519D141438D1",
    "patient_ID": "TCGA.UF.A7JC",
    "bcr_drug_barcode": "TCGA-UF-A7JC-D60396",
    "bcr_drug_uuid": "ACA937EB-EA78-4861-9C8F-A59D61AFACFA",
    "form_completion_date": "2014-6-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3BD2FCEE-5B16-49F3-A717-F1E106BBC12F",
    "patient_ID": "TCGA.UF.A7JF",
    "bcr_drug_barcode": "TCGA-UF-A7JF-D61376",
    "bcr_drug_uuid": "CECD3B5E-EFBB-4887-BD87-698128E8CA5D",
    "form_completion_date": "2014-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "68F612B7-33B4-4CA4-B012-439BFD598888",
    "patient_ID": "TCGA.UF.A7JJ",
    "bcr_drug_barcode": "TCGA-UF-A7JJ-D61379",
    "bcr_drug_uuid": "563F9629-9C8D-427B-A688-8E030C041F9C",
    "form_completion_date": "2014-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1CA54115-93A3-4C0E-ABF0-915B4BBFF10C",
    "patient_ID": "TCGA.UF.A7JK",
    "bcr_drug_barcode": "TCGA-UF-A7JK-D61371",
    "bcr_drug_uuid": "76455436-956B-48B1-8EC1-A59BF38E804C",
    "form_completion_date": "2014-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12DA9527-CF33-46C6-90CF-65478FF15CF9",
    "patient_ID": "TCGA.UF.A7JT",
    "bcr_drug_barcode": "TCGA-UF-A7JT-D61384",
    "bcr_drug_uuid": "2D947D8B-A1DA-44E7-8952-C35E22BA5F20",
    "form_completion_date": "2014-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 173,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  }
]
